{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:49:10Z","timestamp":1787028550890,"version":"build-2736575974"},"reference-count":650,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["22-15-00409"],"award-info":[{"award-number":["22-15-00409"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["0088-2024-0009"],"award-info":[{"award-number":["0088-2024-0009"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Government program of basic research","award":["22-15-00409"],"award-info":[{"award-number":["22-15-00409"]}]},{"name":"Government program of basic research","award":["0088-2024-0009"],"award-info":[{"award-number":["0088-2024-0009"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Discovered in late 2019, the SARS-CoV-2 coronavirus has caused the largest pandemic of the 21st century, claiming more than seven million lives. In most cases, the COVID-19 disease caused by the SARS-CoV-2 virus is relatively mild and affects only the upper respiratory tract; it most often manifests itself with fever, chills, cough, and sore throat, but also has less-common mild symptoms. In most cases, patients do not require hospitalization, and fully recover. However, in some cases, infection with the SARS-CoV-2 virus leads to the development of a severe form of COVID-19, which is characterized by the development of life-threatening complications affecting not only the lungs, but also other organs and systems. In particular, various forms of thrombotic complications are common among patients with a severe form of COVID-19. The mechanisms for the development of thrombotic complications in COVID-19 remain unclear. Accumulated data indicate that the pathogenesis of severe COVID-19 is based on disruptions in the functioning of various innate immune systems. The key role in the primary response to a viral infection is assigned to two systems. These are the pattern recognition receptors, primarily members of the toll-like receptor (TLR) family, and the complement system. Both systems are the first to engage in the fight against the virus and launch a whole range of mechanisms aimed at its rapid elimination. Normally, their joint activity leads to the destruction of the pathogen and recovery. However, disruptions in the functioning of these innate immune systems in COVID-19 can cause the development of an excessive inflammatory response that is dangerous for the body. In turn, excessive inflammation entails activation of and damage to the vascular endothelium, as well as the development of the hypercoagulable state observed in patients seriously ill with COVID-19. Activation of the endothelium and hypercoagulation lead to the development of thrombosis and, as a result, damage to organs and tissues. Immune-mediated thrombotic complications are termed \u201cimmunothrombosis\u201d. In this review, we discuss in detail the features of immunothrombosis associated with SARS-CoV-2 infection and its potential underlying mechanisms.<\/jats:p>","DOI":"10.3390\/ijms252011267","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T03:57:09Z","timestamp":1729483029000},"page":"11267","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Immunity and Coagulation in COVID-19"],"prefix":"10.3390","volume":"25","author":[{"given":"Piotr P.","family":"Avdonin","sequence":"first","affiliation":[{"name":"Koltzov Institute of Developmental Biology RAS, ul. Vavilova, 26, 119334 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S.","family":"Blinova","sequence":"additional","affiliation":[{"name":"Koltzov Institute of Developmental Biology RAS, ul. Vavilova, 26, 119334 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia A.","family":"Serkova","sequence":"additional","affiliation":[{"name":"Koltzov Institute of Developmental Biology RAS, ul. Vavilova, 26, 119334 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia A.","family":"Komleva","sequence":"additional","affiliation":[{"name":"Koltzov Institute of Developmental Biology RAS, ul. Vavilova, 26, 119334 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4138-1589","authenticated-orcid":false,"given":"Pavel V.","family":"Avdonin","sequence":"additional","affiliation":[{"name":"Koltzov Institute of Developmental Biology RAS, ul. Vavilova, 26, 119334 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/15384047.2021.1890319","article-title":"The role of extracellular DNA (exdna) in cellular processes","volume":"22","year":"2021","journal-title":"Cancer Biol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/path.5642","article-title":"COVID-19: Immunopathology, pathophysiological mechanisms, and treatment options","volume":"254","author":"Binkhorst","year":"2021","journal-title":"J. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e060413","DOI":"10.1136\/bmjopen-2021-060413","article-title":"Therapies for long COVID in non-hospitalised individuals: From symptoms, patient-reported outcomes and immunology to targeted therapies (the tlc study)","volume":"12","author":"Haroon","year":"2022","journal-title":"BMJ Open"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/jth.14830","article-title":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia","volume":"18","author":"Cui","year":"2020","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: Evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ancard.2020.09.027","article-title":"COVID-19 and venous thromboembolism","volume":"69","author":"Trimaille","year":"2020","journal-title":"Ann. Cardiol. D\u2019angeiologie"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.120.048488","article-title":"Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy","volume":"142","author":"Nicolai","year":"2020","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fcvm.2020.00151","article-title":"Incidence of venous thromboembolism in hospitalized coronavirus disease 2019 patients: A systematic review and meta-analysis","volume":"7","author":"Zhang","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.120.046702","article-title":"Deep vein thrombosis in hospitalized patients with COVID-19 in Wuhan, China: Prevalence, risk factors, and outcome","volume":"142","author":"Zhang","year":"2020","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41577-022-00762-9","article-title":"Understanding COVID-19-associated coagulopathy","volume":"22","author":"Conway","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/ATVBAHA.120.315338","article-title":"COVID-19 and sepsis are associated with different abnormalities in plasma procoagulant and fibrinolytic activity","volume":"41","author":"Bouck","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e12525","DOI":"10.1002\/rth2.12525","article-title":"Comparison of the coagulopathies associated with COVID-19 and sepsis","volume":"5","author":"Campbell","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","article-title":"Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19","volume":"21","author":"Bonaventura","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1172\/JCI141374","article-title":"Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Marcos-Jubilar, M., Lecumberri, R., and Paramo, J.A. (2023). Immunothrombosis: Molecular aspects and new therapeutic perspectives. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041399"},{"key":"ref_20","first-page":"212","article-title":"Immunothrombosis in acute respiratory distress syndrome: Cross talks between inflammation and coagulation","volume":"93","author":"Frantzeskaki","year":"2017","journal-title":"Respir. Int. Rev. Thorac. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"102322","DOI":"10.1016\/j.ctrv.2021.102322","article-title":"Interplay between coagulation and inflammation in cancer: Limitations and therapeutic opportunities","volume":"102","author":"Bauer","year":"2022","journal-title":"Cancer Treat. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1111\/jth.15852","article-title":"Intracellular communication and immunothrombosis in sepsis","volume":"20","author":"Iba","year":"2022","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Mantovani, S., Oliviero, B., Varchetta, S., Renieri, A., and Mondelli, M.U. (2023). TLRS: Innate immune sentries against SARS-CoV-2 infection. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24098065"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"100995","DOI":"10.1016\/j.blre.2022.100995","article-title":"Complement activation in COVID-19 and targeted therapeutic options: A scoping review","volume":"57","author":"Lim","year":"2023","journal-title":"Blood Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00018-024-05157-8","article-title":"Emerging role of complement in COVID-19 and other respiratory virus diseases","volume":"81","author":"Xiao","year":"2024","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"152393","DOI":"10.1016\/j.imbio.2023.152393","article-title":"Complement and COVID-19: Three years on, what we know, what we don\u2019t know, and what we ought to know","volume":"228","author":"Zelek","year":"2023","journal-title":"Immunobiology"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Silva, M.J.A., Ribeiro, L.R., Gouveia, M.I.M., Marcelino, B.D.R., Santos, C.S.D., Lima, K.V.B., and Lima, L. (2023). Hyperinflammatory response in COVID-19: A systematic review. Viruses, 15.","DOI":"10.3390\/v15020553"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight","volume":"171","author":"Markiewski","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"812774","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/path.2264","article-title":"The role of TLR activation in inflammation","volume":"214","author":"Sabroe","year":"2008","journal-title":"J. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Wilhelm, G., Mertowska, P., Mertowski, S., Przysucha, A., Struzyna, J., Grywalska, E., and Torres, K. (2023). The crossroads of the coagulation system and the immune system: Interactions and connections. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612563"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/eji.201847811","article-title":"Soluble pattern recognition molecules: Guardians and regulators of homeostasis at airway mucosal surfaces","volume":"50","author":"Smole","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12026-020-09137-5","article-title":"COVID-19: A clue from innate immunity","volume":"68","author":"Birra","year":"2020","journal-title":"Immunol. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.1096\/fj.202001115R","article-title":"Genetic gateways to COVID-19 infection: Implications for risk, severity, and outcomes","volume":"34","author":"Debnath","year":"2020","journal-title":"FASEB J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1473-3099(11)70099-8","article-title":"Targeting of toll-like receptors: A decade of progress in combating infectious diseases","volume":"11","author":"Hedayat","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3349\/ymj.2011.52.3.379","article-title":"Intrinsic and extrinsic regulation of innate immune receptors","volume":"52","author":"Jeong","year":"2011","journal-title":"Yonsei Med. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1111\/j.1582-4934.2010.01127.x","article-title":"Endogenous toll-like receptor ligands and their biological significance","volume":"14","author":"Yu","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"8874339","DOI":"10.1155\/2021\/8874339","article-title":"COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ace2 expression, facilitating entry and causing hyperinflammation","volume":"2021","author":"Aboudounya","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.4110\/in.2018.18.e27","article-title":"Damage-associated molecular patterns in inflammatory diseases","volume":"18","author":"Roh","year":"2018","journal-title":"Immune Netw."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1157023","DOI":"10.1155\/2021\/1157023","article-title":"Toll-like receptors (TLRS): Structure, functions, signaling, and role of their polymorphisms in colorectal cancer susceptibility","volume":"2021","author":"Sameer","year":"2021","journal-title":"BioMed Res. Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Bortolotti, D., Gentili, V., Rizzo, S., Schiuma, G., Beltrami, S., Strazzabosco, G., Fernandez, M., Caccuri, F., Caruso, A., and Rizzo, R. (2021). TLR3 and TLR7 RNA sensor activation during SARS-CoV-2 infection. Microorganisms, 9.","DOI":"10.3390\/microorganisms9091820"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41590-021-00962-w","article-title":"SARS-CoV-2 takes its toll","volume":"22","author":"Sariol","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"184328","DOI":"10.1155\/2010\/184328","article-title":"The battle between virus and host: Modulation of toll-like receptor signaling pathways by virus infection","volume":"2010","author":"Yokota","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Ebermeyer, T., Cognasse, F., Berthelot, P., Mismetti, P., Garraud, O., and Hamzeh-Cognasse, H. (2021). Platelet innate immune receptors and TLRS: A double-edged sword. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22157894"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine storm in COVID-19: The current evidence and treatment strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/jmv.27405","article-title":"Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19","volume":"94","author":"Manik","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"989664","DOI":"10.3389\/fphar.2022.989664","article-title":"Toll-like receptor (TLRS) agonists and antagonists for COVID-19 treatments","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1471-4906(03)00242-4","article-title":"Leucine-rich repeats and pathogen recognition in toll-like receptors","volume":"24","author":"Bell","year":"2003","journal-title":"Trends Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"9914854","DOI":"10.1155\/2021\/9914854","article-title":"Toll-like receptors: General molecular and structural biology","volume":"2021","author":"Behzadi","year":"2021","journal-title":"J. Immunol. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.cellbio.21.122303.115827","article-title":"Recognition and signaling by toll-like receptors","volume":"22","author":"West","year":"2006","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.biochem.76.060305.151318","article-title":"Structure and function of toll receptors and their ligands","volume":"76","author":"Gay","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00011-010-0208-2","article-title":"Important aspects of toll-like receptors, ligands and their signaling pathways","volume":"59","author":"Chang","year":"2010","journal-title":"Inflamm. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/0471142735.im1412s109","article-title":"Toll-like receptors","volume":"109","author":"Takeda","year":"2015","journal-title":"Curr. Protoc. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/CMR.16.4.637-646.2003","article-title":"Role of toll-like receptors in pathogen recognition","volume":"16","author":"Janssens","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"672395","DOI":"10.1155\/2010\/672395","article-title":"Dampening inflammation by modulating TLR signalling","volume":"2010","author":"Piccinini","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri2215","article-title":"How dying cells alert the immune system to danger","volume":"8","author":"Kono","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1538-7836.2009.03334.x","article-title":"Abnormal platelet function in c3-deficient mice","volume":"7","author":"Gushiken","year":"2009","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.imbio.2008.12.003","article-title":"TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of il-1beta and caspase-1 in monocytes and dendritic cells","volume":"214","author":"Hurst","year":"2009","journal-title":"Immunobiology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.imbio.2009.03.002","article-title":"Human antiphospholipid antibodies induce tnfalpha in monocytes via toll-like receptor 8","volume":"215","author":"Doring","year":"2010","journal-title":"Immunobiology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"620972","DOI":"10.3389\/fimmu.2020.620972","article-title":"Cell surface expression of endosomal toll-like receptors\u2014A necessity or a superfluous duplication?","volume":"11","author":"Mielcarska","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1074\/jbc.M112.413922","article-title":"The role of UNC93B1 protein in surface localization of TLR3 receptor and in cell priming to nucleic acid agonists","volume":"288","author":"Pohar","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_66","first-page":"11","article-title":"mast cell toll-like receptors (TLRS)","volume":"64","author":"Wierzbicki","year":"2010","journal-title":"Postep. Hig. Med. Dosw."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1189\/jlb.69.3.474","article-title":"Differential expression of toll-like receptor 2 in human cells","volume":"69","author":"Flo","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"9874109","DOI":"10.1155\/2018\/9874109","article-title":"The role of toll-like receptor signaling in the progression of heart failure","volume":"2018","author":"Yu","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_69","first-page":"79","article-title":"The role of TLR2 in infection and immunity","volume":"3","author":"Massari","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Colleselli, K., Stierschneider, A., and Wiesner, C. (2023). An update on toll-like receptor 2, its function and dimerization in pro- and anti-inflammatory processes. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241512464"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fimmu.2014.00316","article-title":"A comparative review of toll-like receptor 4 expression and functionality in different animal species","volume":"5","author":"Vaure","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1038\/emm.2013.97","article-title":"Recognition of lipopolysaccharide pattern by TLR4 complexes","volume":"45","author":"Park","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1189\/jlb.3HI0816-368RR","article-title":"Frontline science: Nasal epithelial gm-csf contributes to TLR5-mediated modulation of airway dendritic cells and subsequent iga response","volume":"102","author":"Cao","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.4049\/jimmunol.1101895","article-title":"Airway epithelial expression of TLR5 is downregulated in healthy smokers and smokers with chronic obstructive pulmonary disease","volume":"189","author":"Wang","year":"2012","journal-title":"J. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/cmi.2017.122","article-title":"TLR5: Beyond the recognition of flagellin","volume":"14","author":"Yang","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaci.2004.03.049","article-title":"Activation of mast cells by double-stranded RNA: Evidence for activation through toll-like receptor 3","volume":"114","author":"Kulka","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.4049\/jimmunol.176.6.3804","article-title":"Microglia recognize double-stranded rna via TLR3","volume":"176","author":"Town","year":"2006","journal-title":"J. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.4049\/jimmunol.1300376","article-title":"A synthetic TLR3 ligand mitigates profibrotic fibroblast responses by inducing autocrine ifn signaling","volume":"191","author":"Fang","year":"2013","journal-title":"J. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"15408","DOI":"10.1074\/jbc.M117.784090","article-title":"Surface toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness","volume":"292","author":"Bugge","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: An accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.4049\/jimmunol.171.6.3154","article-title":"Subcellular localization of toll-like receptor 3 in human dendritic cells","volume":"171","author":"Matsumoto","year":"2003","journal-title":"J. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/rmv.680","article-title":"Antiviral responses induced by the TLR3 pathway","volume":"21","author":"Matsumoto","year":"2011","journal-title":"Rev. Med. Virol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5114\/ceji.2016.65131","article-title":"Expression of surface and intracellular toll-like receptors by mature mast cells","volume":"41","author":"Agier","year":"2016","journal-title":"Cent.-Eur. J. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Turton, H.A., Thompson, A.A.R., and Farkas, L. (2020). Rna signaling in pulmonary arterial hypertension-a double-stranded sword. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093124"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"20406","DOI":"10.1038\/s41598-019-56914-w","article-title":"Innate immune responses through toll-like receptor 3 require human-antigen-r-mediated atp6v0d2 mRNA stabilization","volume":"9","author":"Zainol","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"36836","DOI":"10.1074\/jbc.M110.167973","article-title":"Dimerization of toll-like receptor 3 (TLR3) is required for ligand binding","volume":"285","author":"Wang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_87","first-page":"96","article-title":"toll-like receptor 8: The awkward TLR","volume":"28","author":"Alexopoulou","year":"2012","journal-title":"Med. Sci. M\/S"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","article-title":"Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to cpg oligodeoxynucleotides","volume":"168","author":"Hornung","year":"2002","journal-title":"J. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e039887","DOI":"10.1136\/bmjopen-2020-039887","article-title":"Age differences in clinical features and outcomes in patients with COVID-19, Jiangsu, China: A retrospective, multicentre cohort study","volume":"10","author":"Luo","year":"2020","journal-title":"BMJ Open"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.4049\/jimmunol.180.4.2117","article-title":"TLR7 is involved in sequence-specific sensing of single-stranded rnas in human macrophages","volume":"180","author":"Gantier","year":"2008","journal-title":"J. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Jung, H.E., and Lee, H.K. (2021). Current understanding of the innate control of toll-like receptors in response to SARS-CoV-2 infection. Viruses, 13.","DOI":"10.3390\/v13112132"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2018.03.013","article-title":"Toll-like receptor 9 contains two DNA binding sites that function cooperatively to promote receptor dimerization and activation","volume":"48","author":"Ohto","year":"2018","journal-title":"Immunity"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/416603a","article-title":"Chromatin-igg complexes activate b cells by dual engagement of igm and toll-like receptors","volume":"416","author":"Leadbetter","year":"2002","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jmb.2013.11.024","article-title":"Toll-like receptors in antiviral innate immunity","volume":"426","author":"Lester","year":"2014","journal-title":"J. Mol. Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_96","first-page":"e68563","article-title":"SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the nf-kappab pathway","volume":"10","author":"Khan","year":"2021","journal-title":"bioRxiv Prepr. Serv. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion mechanism of 2019-nCOV and fusion inhibitors targeting HR1 domain in spike protein","volume":"17","author":"Xia","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1368946","DOI":"10.3389\/fimmu.2024.1368946","article-title":"TLR2\/4 are novel activating receptors for SARS-CoV-2 spike protein on nk cells","volume":"15","author":"Landolina","year":"2024","journal-title":"Frontiers in immunology"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Palestra, F., Poto, R., Ciardi, R., Opromolla, G., Secondo, A., Tedeschi, V., Ferrara, A.L., Di Crescenzo, R.M., Galdiero, M.R., and Cristinziano, L. (2023). SARS-CoV-2 spike protein activates human lung macrophages. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24033036"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e0139621","DOI":"10.1128\/JVI.01396-21","article-title":"Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by simvastatin","volume":"95","author":"Qian","year":"2021","journal-title":"J. Virol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","article-title":"TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines","volume":"22","author":"Zheng","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4103\/ijmr.IJMR_131_21","article-title":"Expression of innate immune response genes in upper airway samples of SARS-CoV-2 infected patients: A preliminary study","volume":"153","author":"Mohanty","year":"2021","journal-title":"Indian J. Med. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jfma.2021.06.009","article-title":"Innate immune response analysis in COVID-19 and kawasaki disease reveals mis-c predictors","volume":"121","author":"Yang","year":"2022","journal-title":"J. Formos. Med. Assoc. Taiwan Yi Zhi"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","article-title":"SARS-CoV-2 spike protein interacts with and activates TLR41","volume":"31","author":"Zhao","year":"2021","journal-title":"Cell Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/jmv.25987","article-title":"In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRS","volume":"92","author":"Choudhury","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e06187","DOI":"10.1016\/j.heliyon.2021.e06187","article-title":"SARS-CoV-2 spike protein s1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages","volume":"7","author":"Shirato","year":"2021","journal-title":"Heliyon"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbi.2021.12.007","article-title":"SARS-CoV-2 spike s1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of pamp-like properties","volume":"100","author":"Frank","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41392-021-00653-w","article-title":"Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri3133","article-title":"Immunomodulatory functions of type i interferons","volume":"12","author":"Lee","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1084\/jem.20080091","article-title":"Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-i and melanoma differentiation-associated gene 5","volume":"205","author":"Kato","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3389\/fimmu.2019.01586","article-title":"Comparative structure and function analysis of the rig-i-like receptors: Rig-i and mda5","volume":"10","author":"Brisse","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"104960","DOI":"10.1016\/j.jbc.2023.104960","article-title":"Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease","volume":"299","author":"Samuel","year":"2023","journal-title":"J. Biol. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e00638","DOI":"10.1128\/mBio.00638-15","article-title":"Toll-like receptor 3 signaling via trif contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection","volume":"6","author":"Totura","year":"2015","journal-title":"mBio"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e67569","DOI":"10.7554\/eLife.67569","article-title":"Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study","volume":"10","author":"Fallerini","year":"2021","journal-title":"Elife"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.maturitas.2022.03.004","article-title":"Gender differences in COVID-19","volume":"161","author":"Paschou","year":"2022","journal-title":"Maturitas"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jmv.26387","article-title":"Targeting human TLRS to combat COVID-19: A solution?","volume":"93","author":"Patra","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.3346\/jkms.2020.35.e343","article-title":"COVID-19 patients upregulate toll-like receptor 4-mediated inflammatory signaling that mimics bacterial sepsis","volume":"35","author":"Sohn","year":"2020","journal-title":"J. Korean Med. Sci."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Kayesh, M.E.H., Kohara, M., and Tsukiyama-Kohara, K. (2021). An overview of recent insights into the response of TLR to SARS-CoV-2 infection and the potential of TLR agonists as SARS-CoV-2 vaccine adjuvants. Viruses, 13.","DOI":"10.3390\/v13112302"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e20201129","DOI":"10.1084\/jem.20201129","article-title":"SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology","volume":"217","author":"Veras","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/s41366-021-00768-8","article-title":"Increased TLR\/MYD88 signaling in patients with obesity: Is there a link to COVID-19 disease severity?","volume":"45","author":"Cuevas","year":"2021","journal-title":"Int. J. Obes."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.7150\/ijbs.77561","article-title":"Pyroptotic cell death in SARS-CoV-2 infection: Revealing its roles during the immunopathogenesis of COVID-19","volume":"18","author":"Wang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.imlet.2020.06.013","article-title":"Lymphopenia during the COVID-19 infection: What it shows and what can be learned","volume":"225","author":"Tavakolpour","year":"2020","journal-title":"Immunol. Lett."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/imm.13623","article-title":"The role of hmgb1 in COVID-19-induced cytokine storm and its potential therapeutic targets: A review","volume":"169","author":"Wulandari","year":"2023","journal-title":"Immunology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1084\/jem.20141318","article-title":"Md-2 is required for disulfide hmgb1-dependent TLR4 signaling","volume":"212","author":"Yang","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"7527953","DOI":"10.1155\/2020\/7527953","article-title":"Neutrophil extracellular traps (nets) and damage-associated molecular patterns (damps): Two potential targets for COVID-19 treatment","volume":"2020","author":"Cicco","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cytogfr.2021.10.004","article-title":"S100a8\/a9 in COVID-19 pathogenesis: Impact on clinical outcomes","volume":"63","author":"Mellett","year":"2022","journal-title":"Cytokine Growth Factor. Rev."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e20200183","DOI":"10.1590\/1678-9199-jvatitd-2020-0183","article-title":"Through DNA sensors and hidden mitochondrial effects of SARS-CoV-2","volume":"27","author":"Targhetta","year":"2021","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.addr.2007.12.004","article-title":"TLR9 as a key receptor for the recognition of DNA","volume":"60","author":"Kumagai","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/eji.201343882","article-title":"Endocytosis-free DNA sensing by cell surface TLR9 in neutrophils: Rapid defense with autoimmune risks","volume":"43","author":"Miyake","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e147610","DOI":"10.1172\/jci.insight.147610","article-title":"Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury","volume":"6","author":"Andargie","year":"2021","journal-title":"JCI Insight"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"600881","DOI":"10.3389\/fmolb.2021.600881","article-title":"Circulating nucleosomes as potential markers to monitor COVID-19 disease progression","volume":"8","author":"Cavalier","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.molimm.2015.01.028","article-title":"Complement in therapy and disease: Regulating the complement system with antibody-based therapeutics","volume":"67","author":"Melis","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ni.3858","article-title":"Novel mechanisms and functions of complement","volume":"18","author":"Hajishengallis","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"624025","DOI":"10.3389\/fcell.2021.624025","article-title":"Complement receptors and their role in leukocyte recruitment and phagocytosis","volume":"9","author":"Vandendriessche","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00281-021-00892-7","article-title":"Tipping the balance: Intricate roles of the complement system in disease and therapy","volume":"43","author":"Pouw","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00281-017-0644-y","article-title":"Complement as a regulator of adaptive immunity","volume":"40","author":"Killick","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12026-012-8327-1","article-title":"Complement regulation of t cell immunity","volume":"54","author":"Kwan","year":"2012","journal-title":"Immunol. Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.immuni.2008.02.001","article-title":"Locally produced complement fragments c5a and c3a provide both costimulatory and survival signals to naive cd4+ t cells","volume":"28","author":"Strainic","year":"2008","journal-title":"Immunity"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: A key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41581-023-00704-1","article-title":"Complosome\u2014The intracellular complement system","volume":"19","author":"West","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1556\/EuJMI.2.2012.2.2","article-title":"The complement system: History, pathways, cascade and inhibitors","volume":"2","author":"Nesargikar","year":"2012","journal-title":"Eur. J. Microbiol. Immunol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2119\/molmed.2010.00149","article-title":"New insights of an old defense system: Structure, function, and clinical relevance of the complement system","volume":"17","author":"Ehrnthaller","year":"2011","journal-title":"Mol. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.120.3112.279","article-title":"The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena","volume":"120","author":"Pillemer","year":"1954","journal-title":"Science"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/0006-291X(78)91452-3","article-title":"Isolation and characterization of a mannan-binding protein from rabbit liver","volume":"81","author":"Kawasaki","year":"1978","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.164.5.2281","article-title":"Cutting edge: Complement-activating complex of ficolin and mannose-binding lectin-associated serine protease","volume":"164","author":"Matsushita","year":"2000","journal-title":"J. Immunol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1084\/jem.176.6.1497","article-title":"Activation of the classical complement pathway by mannose-binding protein in association with a novel c1s-like serine protease","volume":"176","author":"Matsushita","year":"1992","journal-title":"J. Exp. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.4049\/jimmunol.168.7.3502","article-title":"Activation of the lectin complement pathway by h-ficolin (hakata antigen)","volume":"168","author":"Matsushita","year":"2002","journal-title":"J. Immunol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.4049\/jimmunol.165.5.2637","article-title":"Proteolytic activities of two types of mannose-binding lectin-associated serine protease","volume":"165","author":"Matsushita","year":"2000","journal-title":"J. Immunol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.ajpath.2020.02.006","article-title":"Complement membrane attack complex: New roles, mechanisms of action, and therapeutic targets","volume":"190","author":"Xie","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2567.2007.02535.x","article-title":"Studies on the interactions between c-reactive protein and complement proteins","volume":"121","author":"Biro","year":"2007","journal-title":"Immunology"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.it.2008.11.003","article-title":"Complement activation and inhibition: A delicate balance","volume":"30","author":"Sjoberg","year":"2009","journal-title":"Trends Immunol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/emboj\/21.3.231","article-title":"The crystal structure of the zymogen catalytic domain of complement protease c1r reveals that a disruptive mechanical stress is required to trigger activation of the c1 complex","volume":"21","author":"Lacroix","year":"2002","journal-title":"EMBO J."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.molimm.2007.09.031","article-title":"Revisiting the mechanism of the autoactivation of the complement protease c1r in the c1 complex: Structure of the active catalytic region of c1r","volume":"45","author":"Kardos","year":"2008","journal-title":"Mol. Immunol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1073\/pnas.1616998114","article-title":"Structure and activation of c1, the complex initiating the classical pathway of the complement cascade","volume":"114","author":"Mortensen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cll.2019.07.006","article-title":"Analysis of the complement system in the clinical immunology laboratory","volume":"39","author":"Ling","year":"2019","journal-title":"Clin. Lab. Med."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1073\/pnas.1202588109","article-title":"Revised mechanism of complement lectin-pathway activation revealing the role of serine protease masp-1 as the exclusive activator of masp-2","volume":"109","author":"Heja","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1399-0039.2006.00649.x","article-title":"Mannose-binding lectin in innate immunity: Past, present and future","volume":"68","author":"Dommett","year":"2006","journal-title":"Tissue Antigens"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.biocel.2011.02.003","article-title":"The role of ficolins in the lectin pathway of innate immunity","volume":"43","author":"Endo","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.4049\/jimmunol.1002185","article-title":"Collectin 11 (cl-11, cl-k1) is a masp-1\/3-associated plasma collectin with microbial-binding activity","volume":"185","author":"Hansen","year":"2010","journal-title":"J. Immunol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.virol.2010.12.045","article-title":"Complement and viral pathogenesis","volume":"411","author":"Stoermer","year":"2011","journal-title":"Virology"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4049\/jimmunol.176.3.1305","article-title":"The central role of the alternative complement pathway in human disease","volume":"176","author":"Thurman","year":"2006","journal-title":"J. Immunol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1084\/jem.154.3.856","article-title":"Formation of the initial c3 convertase of the alternative complement pathway. Acquisition of c3b-like activities by spontaneous hydrolysis of the putative thioester in native c3","volume":"154","author":"Pangburn","year":"1981","journal-title":"J. Exp. Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3389\/fimmu.2020.00530","article-title":"Assessment of the role of C3(H2O) in the alternative pathway","volume":"11","author":"Fromell","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.molimm.2007.11.003","article-title":"The tick-over theory revisited: Formation and regulation of the soluble alternative complement c3 convertase (C3(H2O)Bb)","volume":"45","author":"Bexborn","year":"2008","journal-title":"Mol. Immunol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nsmb1210","article-title":"Factor b structure provides insights into activation of the central protease of the complement system","volume":"14","author":"Milder","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.1195821","article-title":"Structures of c3b in complex with factors b and d give insight into complement convertase formation","volume":"330","author":"Forneris","year":"2010","journal-title":"Science"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1038\/emboj.2009.184","article-title":"Insights into complement convertase formation based on the structure of the factor b-cobra venom factor complex","volume":"28","author":"Janssen","year":"2009","journal-title":"EMBO J."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","article-title":"The role of the anaphylatoxins in health and disease","volume":"46","author":"Klos","year":"2009","journal-title":"Mol. Immunol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ni.1756","article-title":"Structural and functional implications of the alternative complement pathway c3 convertase stabilized by a staphylococcal inhibitor","volume":"10","author":"Rooijakkers","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3389\/fimmu.2018.01691","article-title":"Functional characterization of alternative and classical pathway c3\/c5 convertase activity and inhibition using purified models","volume":"9","author":"Zwarthoff","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1582-4934.2008.00350.x","article-title":"The alternative complement pathway revisited","volume":"12","author":"Harboe","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41598-022-27279-4","article-title":"Purified complement c3b triggers phagocytosis and activation of human neutrophils via complement receptor 1","volume":"13","author":"Boero","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.4049\/jimmunol.141.11.3895","article-title":"C5 convertase of the alternative complement pathway: Covalent linkage between two c3b molecules within the trimolecular complex enzyme","volume":"141","author":"Kinoshita","year":"1988","journal-title":"J. Immunol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1567-5769(00)00039-4","article-title":"Structure\/function of c5 convertases of complement","volume":"1","author":"Rawal","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1042\/bst0301006","article-title":"Structure and function of complement c5 convertase enzymes","volume":"30","author":"Pangburn","year":"2002","journal-title":"Biochem. Soc. Trans."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1021\/bi500157z","article-title":"The making of a macromolecular machine: Assembly of the membrane attack complex","volume":"53","author":"Bubeck","year":"2014","journal-title":"Biochemistry"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4049\/jimmunol.135.1.445","article-title":"The membrane attack complex of complement: Relation of c7 to the metastable membrane binding site of the intermediate complex c5b-7","volume":"135","author":"Preissner","year":"1985","journal-title":"J. Immunol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1038\/s41467-018-07653-5","article-title":"Cryoem reveals how the complement membrane attack complex ruptures lipid bilayers","volume":"9","author":"Menny","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/eji.200636285","article-title":"Terminal complement complex c5b-9-treated human monocyte-derived dendritic cells undergo maturation and induce th1 polarization","volume":"37","author":"Chen","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of c5a in the absence of c3: A new complement activation pathway","volume":"12","author":"Sarma","year":"2006","journal-title":"Nat. Med."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clim.2005.10.014","article-title":"Membrane complement regulatory proteins","volume":"118","author":"Kim","year":"2006","journal-title":"Clin. Immunol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin. Nephrol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1016\/j.molimm.2008.06.028","article-title":"Biological activities of c1 inhibitor","volume":"45","author":"Davis","year":"2008","journal-title":"Mol. Immunol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.iy.07.040189.000343","article-title":"Decay-accelerating factor: Biochemistry, molecular biology, and function","volume":"7","author":"Lublin","year":"1989","journal-title":"Annu. Rev. Immunol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.4049\/jimmunol.168.12.6298","article-title":"Role of membrane cofactor protein (cd46) in regulation of c4b and c3b deposited on cells","volume":"168","author":"Liszewski","year":"2002","journal-title":"J. Immunol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"37692","DOI":"10.1074\/jbc.M004650200","article-title":"Dissecting sites important for complement regulatory activity in membrane cofactor protein (mcp; cd46)","volume":"275","author":"Liszewski","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Hardy, M.P., Mansour, M., Rowe, T., and Wymann, S. (2023). The molecular mechanisms of complement receptor 1-it is complicated. Biomolecules, 13.","DOI":"10.3390\/biom13101522"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1084\/jem.153.5.1138","article-title":"Complement receptor is an inhibitor of the complement cascade","volume":"153","author":"Iida","year":"1981","journal-title":"J. Exp. Med."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4049\/jimmunol.146.2.656","article-title":"Proposed structure of the f\u2019 allotype of human cr1. Loss of a c3b binding site may be associated with altered function","volume":"146","author":"Wong","year":"1991","journal-title":"J. Immunol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.molimm.2011.04.004","article-title":"Complement factor i in health and disease","volume":"48","author":"Nilsson","year":"2011","journal-title":"Mol. Immunol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00018-016-2418-4","article-title":"Complement factor h in host defense and immune evasion","volume":"74","author":"Parente","year":"2017","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4049\/jimmunol.122.1.75","article-title":"Human alternative complement pathway: Membrane-associated sialic acid regulates the competition between b and beta1 h for cell-bound c3b","volume":"122","author":"Kazatchkine","year":"1979","journal-title":"J. Immunol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor h reduce binding affinity to c3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome","volume":"111","author":"Manuelian","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.4049\/jimmunol.119.6.2024","article-title":"The sc5b-7 complex: Formation, isolation, properties, and subunit composition","volume":"119","author":"Podack","year":"1977","journal-title":"J. Immunol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.4049\/jimmunol.151.4.2159","article-title":"Clusterin, the human apolipoprotein and complement inhibitor, binds to complement c7, c8 beta, and the b domain of c9","volume":"151","author":"Tschopp","year":"1993","journal-title":"J. Immunol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Whinnery, C.D., Nie, Y., Boskovic, D.S., Soriano, S., and Kirsch, W.M. (2024). Cd59 protects primary human cerebrovascular smooth muscle cells from cytolytic membrane attack complex. Brain Sci., 14.","DOI":"10.21203\/rs.3.rs-4165045\/v1"},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Avdonin, P.P., Blinova, M.S., Generalova, G.A., Emirova, K.M., and Avdonin, P.V. (2023). The role of the complement system in the pathogenesis of infectious forms of hemolytic uremic syndrome. Biomolecules, 14.","DOI":"10.3390\/biom14010039"},{"key":"ref_200","first-page":"e52991","article-title":"Complements and their role in systemic disorders","volume":"16","author":"Wang","year":"2024","journal-title":"Cureus"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/infdis\/jiaa646","article-title":"Complement activation in the disease course of coronavirus disease 2019 and its effects on clinical outcomes","volume":"223","author":"Grondman","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"25018","DOI":"10.1073\/pnas.2010540117","article-title":"Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients","volume":"117","author":"Holter","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"e1413","DOI":"10.1002\/cti2.1413","article-title":"SARS-CoV-2 triggers complement activation through interactions with heparan sulfate","volume":"11","author":"Lo","year":"2022","journal-title":"Clin. Transl. Immunol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.2020008248","article-title":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor d inhibition","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41392-022-01133-5","article-title":"Highly pathogenic coronavirus n protein aggravates inflammation by masp-2-mediated lectin complement pathway overactivation","volume":"7","author":"Gao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3389\/fimmu.2017.01795","article-title":"Editorial: Natural antibodies in health and disease","volume":"8","author":"Hernandez","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/cid\/ciaa1150","article-title":"Relationship between the abo blood group and the coronavirus disease 2019 (COVID-19) susceptibility","volume":"73","author":"Zhao","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_208","first-page":"2113","article-title":"Testing the association between blood type and COVID-19 infection, intubation, and death","volume":"99","author":"Zietz","year":"2020","journal-title":"medRxiv Prepr. Serv. Health Sci."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00277-021-04489-w","article-title":"Association between abo blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: A literature review of 23 studies","volume":"100","author":"Zhang","year":"2021","journal-title":"Ann. Hematol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1182\/blood.V99.7.2477","article-title":"Expression of abo or related antigenic carbohydrates on viral envelopes leads to neutralization in the presence of serum containing specific natural antibodies and complement","volume":"99","author":"Preece","year":"2002","journal-title":"Blood"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/glycob\/cwn093","article-title":"Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies","volume":"18","author":"Guillon","year":"2008","journal-title":"Glycobiology"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"eabh2259","DOI":"10.1126\/sciimmunol.abh2259","article-title":"Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection","volume":"6","author":"Ma","year":"2021","journal-title":"Sci. Immunol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41577-021-00665-1","article-title":"The state of complement in COVID-19","volume":"22","author":"Afzali","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-020-2600-6","article-title":"Association of COVID-19 inflammation with activation of the c5a-c5ar1 axis","volume":"588","author":"Carvelli","year":"2020","journal-title":"Nature"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.it.2010.01.002","article-title":"Crosstalk pathways between toll-like receptors and the complement system","volume":"31","author":"Hajishengallis","year":"2010","journal-title":"Trends Immunol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/iai.16.3.748-753.1977","article-title":"Activation of complement by opportunist pathogens and chemotypes of salmonella minnesota","volume":"16","author":"Bjornson","year":"1977","journal-title":"Infect. Immun."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4049\/jimmunol.118.1.362","article-title":"Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (lps)","volume":"118","author":"Morrison","year":"1977","journal-title":"J. Immunol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.shk.0000155350.95435.28","article-title":"Zymosan-induced generalized inflammation: Experimental studies into mechanisms leading to multiple organ dysfunction syndrome","volume":"23","author":"Volman","year":"2005","journal-title":"Shock"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2006-12-063636","article-title":"Regulation of toll-like receptor-mediated inflammatory response by complement in vivo","volume":"110","author":"Zhang","year":"2007","journal-title":"Blood"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.4049\/jimmunol.175.7.4706","article-title":"Gc1q receptor ligation selectively down-regulates human il-12 production through activation of the phosphoinositide 3-kinase pathway","volume":"175","author":"Waggoner","year":"2005","journal-title":"J. Immunol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.273.5272.228","article-title":"Mechanism of suppression of cell-mediated immunity by measles virus","volume":"273","author":"Karp","year":"1996","journal-title":"Science"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1084\/jem.185.11.1987","article-title":"Regulation of interleukin-12 by complement receptor 3 signaling","volume":"185","author":"Marth","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.immuni.2005.02.006","article-title":"C5a negatively regulates toll-like receptor 4-induced immune responses","volume":"22","author":"Hawlisch","year":"2005","journal-title":"Immunity"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.4049\/jimmunol.175.5.2994","article-title":"G(i)-protein-dependent inhibition of il-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase b\/akt pathway and jnk","volume":"175","author":"Gadina","year":"2005","journal-title":"J. Immunol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/eji.201040355","article-title":"Complement fragments c3a and c5a: The salt and pepper of the immune response","volume":"40","author":"Sacks","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1182\/blood-2008-05-156646","article-title":"Cyclic amp plays a critical role in c3a-receptor-mediated regulation of dendritic cells in antigen uptake and t-cell stimulation","volume":"112","author":"Li","year":"2008","journal-title":"Blood"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.4049\/jimmunol.0804186","article-title":"Dendritic cell function in allostimulation is modulated by c5ar signaling","volume":"183","author":"Peng","year":"2009","journal-title":"J. Immunol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.4049\/jimmunol.164.6.3009","article-title":"Selective suppression of il-12 production by chemoattractants","volume":"164","author":"Braun","year":"2000","journal-title":"J. Immunol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1172\/JCI31720","article-title":"Apc-derived cytokines and t cell polarization in autoimmune inflammation","volume":"117","author":"Gutcher","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"750374","DOI":"10.1155\/2014\/750374","article-title":"Cellular factors targeting apcs to modulate adaptive t cell immunity","volume":"2014","author":"Visperas","year":"2014","journal-title":"J. Immunol. Res."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fimmu.2019.00360","article-title":"Cross-talk between antigen presenting cells and t cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis","volume":"10","author":"Gaudino","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"Il-6: Regulator of treg\/th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1182\/blood-2009-01-198283","article-title":"Complement promotes the development of inflammatory t-helper 17 cells through synergistic interaction with toll-like receptor signaling and interleukin-6 production","volume":"114","author":"Fang","year":"2009","journal-title":"Blood"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nri2225","article-title":"How microorganisms tip the balance between interleukin-12 family members","volume":"8","author":"Goriely","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1535370218824547","article-title":"Il-12 and il-23\/th17 axis in systemic lupus erythematosus","volume":"244","author":"Larosa","year":"2019","journal-title":"Exp. Biol. Med."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.celrep.2018.02.044","article-title":"Il-23 and il-1beta drive human th17 cell differentiation and metabolic reprogramming in absence of cd28 costimulation","volume":"22","author":"Revu","year":"2018","journal-title":"Cell Rep."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.4049\/jimmunol.177.8.5377","article-title":"Two-sided roles of il-27: Induction of th1 differentiation on naive cd4+ t cells versus suppression of proinflammatory cytokine production including il-23-induced il-17 on activated cd4+ t cells partially through stat3-dependent mechanism","volume":"177","author":"Yoshimura","year":"2006","journal-title":"J. Immunol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20092301","article-title":"Complement drives th17 cell differentiation and triggers autoimmune arthritis","volume":"207","author":"Hashimoto","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1189\/jlb.0809588","article-title":"Pivotal advance: The pattern recognition receptor ligands lipopolysaccharide and polyinosine-polycytidylic acid stimulate factor b synthesis by the macrophage through distinct but overlapping mechanisms","volume":"88","author":"Kaczorowski","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/eji.201041350","article-title":"TLR activation enhances c5a-induced pro-inflammatory responses by negatively modulating the second c5a receptor, c5l2","volume":"41","author":"Raby","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/jmv.26776","article-title":"In silico analyses on the comparative sensing of SARS-CoV-2 MRNA by the intracellular TLRS of humans","volume":"93","author":"Choudhury","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals il-6 and il-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/infdis\/jiab005","article-title":"Early differences in cytokine production by severity of coronavirus disease 2019","volume":"223","author":"Tjan","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"570698","DOI":"10.3389\/fphar.2020.570698","article-title":"Tempering macrophage plasticity for controlling SARS-CoV-2 infection for managing COVID-19 disease","volume":"11","author":"Toor","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Netea","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41392-022-01106-8","article-title":"Alveolar macrophages: Achilles\u2019 heel of SARS-CoV-2 infection","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"763313","DOI":"10.3389\/fimmu.2021.763313","article-title":"Macrophage activation syndrome and COVID 19: Impact of mapk driven immune-epigenetic programming by SARS-CoV-2","volume":"12","author":"Roy","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"e209666","DOI":"10.1001\/jamanetworkopen.2020.9666","article-title":"Coronavirus disease 2019 (COVID-2019) infection among health care workers and implications for prevention measures in a tertiary hospital in Wuhan, China","volume":"3","author":"Lai","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2141","article-title":"Interleukin-6 in COVID-19: A systematic review and meta-analysis","volume":"30","author":"Coomes","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.immunol.18.1.451","article-title":"Signaling and transcription in t helper development","volume":"18","author":"Murphy","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"e13304","DOI":"10.1111\/aji.13304","article-title":"COVID-19 and treg\/th17 imbalance: Potential relationship to pregnancy outcomes","volume":"84","author":"Muyayalo","year":"2020","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1136\/gutjnl-2020-321269","article-title":"COVID-19 and immunomodulation in ibd","volume":"69","author":"Neurath","year":"2020","journal-title":"Gut"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3389\/fimmu.2018.01545","article-title":"Regulatory t cells and acute lung injury: Cytokines, uncontrolled inflammation, and therapeutic implications","volume":"9","author":"Lin","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13054-015-0811-2","article-title":"The ratio of th17\/treg cells as a risk indicator in early acute respiratory distress syndrome","volume":"19","author":"Yu","year":"2015","journal-title":"Crit. Care"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1038\/s41467-020-17292-4","article-title":"Marked t cell activation, senescence, exhaustion and skewing towards th17 in patients with COVID-19 pneumonia","volume":"11","author":"Meschiari","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jmii.2020.03.005","article-title":"Th17 responses in cytokine storm of COVID-19: An emerging target of jak2 inhibitor fedratinib","volume":"53","author":"Wu","year":"2020","journal-title":"J. Microbiol. Immunol. Infect. Wei Mian Yu Gan Ran Za Zhi"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"108253","DOI":"10.1016\/j.exer.2020.108253","article-title":"Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients","volume":"200","author":"Santiago","year":"2020","journal-title":"Exp. Eye Res."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"286.e7","DOI":"10.1016\/j.cmi.2020.09.051","article-title":"A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients","volume":"27","author":"Petrone","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"155323","DOI":"10.1016\/j.cyto.2020.155323","article-title":"Cytokine profile and disease severity in patients with COVID-19","volume":"137","author":"Ghazavi","year":"2021","journal-title":"Cytokine"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"eabd2071","DOI":"10.1126\/sciimmunol.abd2071","article-title":"Phenotype and kinetics of SARS-CoV-2-specific t cells in COVID-19 patients with acute respiratory distress syndrome","volume":"5","author":"Weiskopf","year":"2020","journal-title":"Sci. Immunol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"107225","DOI":"10.1016\/j.intimp.2020.107225","article-title":"The deregulated immune reaction and cytokines release storm (crs) in COVID-19 disease","volume":"90","author":"Pasrija","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaci.2020.09.009","article-title":"Compartmental immunophenotyping in COVID-19 ards: A case series","volume":"147","author":"Ronit","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"eabg0833","DOI":"10.1126\/sciimmunol.abg0833","article-title":"SARS-CoV-2 drives jak1\/2-dependent local complement hyperactivation","volume":"6","author":"Yan","year":"2021","journal-title":"Sci. Immunol."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: An overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb","year":"2022","journal-title":"Virol. J."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/S2213-2600(20)30525-7","article-title":"Pathophysiology of COVID-19-associated acute respiratory distress syndrome\u2014Authors\u2019 reply","volume":"9","author":"Grasselli","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"311","DOI":"10.15789\/1563-0625-PCI-2312","article-title":"Plasma cytokines in patients with COVID-19 during acute phase of the disease and following complete recovery","volume":"23","author":"Arsentieva","year":"2021","journal-title":"Med. Immunol."},{"key":"ref_272","first-page":"859","article-title":"Predictive value of specific cytokines for lethal COVID-19 outcome","volume":"12","author":"Arsentieva","year":"2022","journal-title":"\u0418\u043d\u0444\u0435\u043a\u0446\u0438\u044f \u0418 \u0418\u043c\u043c\u0443\u043d\u0438\u0442\u0435\u0442"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10787-022-00992-2","article-title":"COVID-19 and the role of cytokines in this disease","volume":"30","author":"Hasanvand","year":"2022","journal-title":"Inflammopharmacology"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"e13209","DOI":"10.1111\/eci.13209","article-title":"The novel chinese coronavirus (2019-nCOV) infections: Challenges for fighting the storm","volume":"50","author":"Bassetti","year":"2020","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"e2010478","DOI":"10.1001\/jamanetworkopen.2020.10478","article-title":"Venous thrombosis among critically ill patients with coronavirus disease 2019 (COVID-19)","volume":"3","author":"Nahum","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_278","doi-asserted-by":"crossref","unstructured":"Iba, T., Warkentin, T.E., Thachil, J., Levi, M., and Levy, J.H. (2021). Proposal of the definition for COVID-19-associated coagulopathy. J. Clin. Med., 10.","DOI":"10.3390\/jcm10020191"},{"key":"ref_279","doi-asserted-by":"crossref","unstructured":"Seo, J.W., Kim, D.Y., Yun, N., and Kim, D.M. (2022). Coronavirus disease 2019-associated coagulopathy. Microorganisms, 10.","DOI":"10.3390\/microorganisms10081556"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1136\/bmj.316.7141.1328","article-title":"Endothelial cell activation. A central pathophysiological process","volume":"316","author":"Hunt","year":"1998","journal-title":"BMJ"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"2001634","DOI":"10.1183\/13993003.01634-2020","article-title":"Endothelial cell dysfunction: A major player in SARS-CoV-2 infection (COVID-19)?","volume":"56","author":"Huertas","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1056\/NEJMc2011400","article-title":"Multiorgan and renal tropism of SARS-CoV-2","volume":"383","author":"Puelles","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","article-title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in china","volume":"98","author":"Su","year":"2020","journal-title":"Kidney Int."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"1111930","DOI":"10.3389\/fmicb.2022.1111930","article-title":"The role of oxidative stress in the pathogenesis of infections with coronaviruses","volume":"13","author":"Gain","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.ATV.0000150649.39934.13","article-title":"Oxidative stress and vascular disease","volume":"25","author":"Madamanchi","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1089\/ars.2007.1959","article-title":"Nitric oxide in the vasculature: Where does it come from and where does it go? A quantitative perspective","volume":"10","author":"Chen","year":"2008","journal-title":"Antioxid. Redox Signal."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0146-0005(97)80006-7","article-title":"Nitric oxide and platelet function: Implications for neonatology","volume":"21","author":"Cheung","year":"1997","journal-title":"Semin. Perinatol."},{"key":"ref_290","first-page":"109","article-title":"Nitric oxide: Physiology, pathophysiology, and pharmacology","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol. Rev."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"35407","DOI":"10.1074\/jbc.M110.205708","article-title":"Glutathione peroxidase-1 deficiency augments proinflammatory cytokine-induced redox signaling and human endothelial cell activation","volume":"286","author":"Lubos","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/ATVBAHA.110.206433","article-title":"Red cells, hemoglobin, heme, iron, and atherogenesis","volume":"30","author":"Nagy","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"12203","DOI":"10.1073\/pnas.211399398","article-title":"Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs","volume":"98","author":"Quan","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1089\/ars.2012.4641","article-title":"Angiotensin ii, nadph oxidase, and redox signaling in the vasculature","volume":"19","author":"Montezano","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s10930-020-09935-8","article-title":"Role of oxidative stress on SARS-CoV (sars) and SARS-CoV-2 (COVID-19) infection: A review","volume":"39","author":"Suhail","year":"2020","journal-title":"Protein J."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1532\/IJH97.06141","article-title":"Regulation of neutrophil functions by proinflammatory cytokines","volume":"84","author":"Kato","year":"2006","journal-title":"Int. J. Hematol."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1182\/blood-2010-05-283564","article-title":"Complement alternative pathway acts as a positive feedback amplification of neutrophil activation","volume":"117","author":"Camous","year":"2011","journal-title":"Blood"},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijid.2020.07.067","article-title":"What can we learn from a COVID-19 lung biopsy?","volume":"99","author":"Wu","year":"2020","journal-title":"Int. J. Infect. Dis. IJID"},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0014-5793(93)80354-W","article-title":"The role of protein kinase c in the induction of vcam-1 expression on human umbilical vein endothelial cells","volume":"331","author":"Deisher","year":"1993","journal-title":"FEBS Lett."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.yjmcc.2005.11.010","article-title":"Activation of jnk and xanthine oxidase by tnf-alpha impairs nitric oxide-mediated dilation of coronary arterioles","volume":"40","author":"Zhang","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.ATV.0000194074.59584.42","article-title":"Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: A novel pathway relevant to the pathophysiology of endothelium","volume":"26","author":"Meacci","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3109\/10715769109145850","article-title":"Superoxide dismutase therapy for myocardial ischemia","volume":"12\u201313","author":"Downey","year":"1991","journal-title":"Free Radic. Res. Commun."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0092-8674(94)90147-3","article-title":"The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling","volume":"77","author":"Kolesnick","year":"1994","journal-title":"Cell"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/bj3350465","article-title":"Signal transduction of stress via ceramide","volume":"335","author":"Mathias","year":"1998","journal-title":"Biochem. J."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"H1785","DOI":"10.1152\/ajpheart.00318.2002","article-title":"Role of ceramide in tnf-alpha-induced impairment of endothelium-dependent vasorelaxation in coronary arteries","volume":"283","author":"Zhang","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_307","doi-asserted-by":"crossref","unstructured":"Gonzalez, P., Lozano, P., Ros, G., and Solano, F. (2023). Hyperglycemia and oxidative stress: An integral, updated and critical overview of their metabolic interconnections. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119352"},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2337\/diabetes.53.3.743","article-title":"Divergent pathways of gene expression are activated by the rage ligands s100b and age-bsa","volume":"53","author":"Valencia","year":"2004","journal-title":"Diabetes"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"14998","DOI":"10.1016\/S0021-9258(18)42138-2","article-title":"Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins","volume":"267","author":"Neeper","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_310","first-page":"E83","article-title":"The transcription factor nf-kappa b and the regulation of vascular cell function","volume":"20","author":"Hoeth","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"25781","DOI":"10.1074\/jbc.M001235200","article-title":"The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa b, and by 17beta-estradiol through sp-1 in human vascular endothelial cells","volume":"275","author":"Tanaka","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11906-000-0078-z","article-title":"Free radical production and angiotensin","volume":"2","author":"Wolf","year":"2000","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_313","first-page":"40","article-title":"All the \u201crage\u201d in lung disease: The receptor for advanced glycation endproducts (rage) is a major mediator of pulmonary inflammatory responses","volume":"23","author":"Oczypok","year":"2017","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_314","doi-asserted-by":"crossref","unstructured":"Norouzi, M., Norouzi, S., Ruggiero, A., Khan, M.S., Myers, S., Kavanagh, K., and Vemuri, R. (2021). Type-2 diabetes as a risk factor for severe COVID-19 infection. Microorganisms, 9.","DOI":"10.3390\/microorganisms9061211"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2017.02.030","article-title":"Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases","volume":"177","author":"Byun","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_316","first-page":"114","article-title":"The receptor for advanced glycation end product (rage) pathway in COVID-19","volume":"26","author":"Cihangiroglu","year":"2021","journal-title":"Biomark. Biochem. Indic. Expo. Response Susceptibility Chem."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.diabet.2020.07.006","article-title":"Metformin and COVID-19: From cellular mechanisms to reduced mortality","volume":"46","author":"Scheen","year":"2020","journal-title":"Diabetes Metab."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"H252","DOI":"10.1152\/ajpheart.00096.2023","article-title":"Cytokine storm in individuals with severe COVID-19 decreases endothelial cell antioxidant defense via downregulation of the nrf2 transcriptional factor","volume":"325","author":"Rodrigues","year":"2023","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_319","first-page":"1229","article-title":"Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, mcp-1\/je","volume":"136","author":"Rollins","year":"1990","journal-title":"Am. J. Pathol."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bcp.2009.04.029","article-title":"Inflammatory cytokines in vascular dysfunction and vascular disease","volume":"78","author":"Sprague","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1152\/physiolgenomics.00012.2009","article-title":"Nf-kappab regulates thrombin-induced icam-1 gene expression in cooperation with nfat by binding to the intronic nf-kappab site in the icam-1 gene","volume":"38","author":"Xue","year":"2009","journal-title":"Physiol. Genom."},{"key":"ref_323","doi-asserted-by":"crossref","unstructured":"Chakraborty, S., Hu, S.Y., Wu, S.H., Karmenyan, A., and Chiou, A. (2015). The interaction affinity between vascular cell adhesion molecule-1 (vcam-1) and very late antigen-4 (vla-4) analyzed by quantitative fret. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0121399"},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12185-010-0555-3","article-title":"Essential roles of vla-4 in the hematopoietic system","volume":"91","author":"Imai","year":"2010","journal-title":"Int. J. Hematol."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"H926","DOI":"10.1152\/ajpheart.00779.2008","article-title":"Icam-1: Role in inflammation and in the regulation of vascular permeability","volume":"295","author":"Frank","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3389\/fimmu.2017.01878","article-title":"E-selectin ligands in the human mononuclear phagocyte system: Implications for infection, inflammation, and immunotherapy","volume":"8","author":"Silva","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_327","doi-asserted-by":"crossref","unstructured":"Cappenberg, A., Kardell, M., and Zarbock, A. (2022). Selectin-mediated signaling-shedding light on the regulation of integrin activity in neutrophils. Cells, 11.","DOI":"10.3390\/cells11081310"},{"key":"ref_328","doi-asserted-by":"crossref","unstructured":"Milosevic, N., Rutter, M., and David, A. (2022). Endothelial cell adhesion molecules- (un)attainable targets for nanomedicines. Front. Med. Technol., 4.","DOI":"10.3389\/fmedt.2022.846065"},{"key":"ref_329","doi-asserted-by":"crossref","unstructured":"Zhang, J., Alcaide, P., Liu, L., Sun, J., He, A., Luscinskas, F.W., and Shi, G.P. (2011). Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0014525"},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00395-005-0582-z","article-title":"The antiatherogenic and antiinflammatory effect of hdl-associated lysosphingolipids operates via akt -->nf-kappab signalling pathways in human vascular endothelial cells","volume":"101","author":"Schmidt","year":"2006","journal-title":"Basic. Res. Cardiol."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0039-6060(96)80317-5","article-title":"Cytokine-induced increases in endothelial permeability occur after adhesion molecule expression","volume":"120","author":"Marcus","year":"1996","journal-title":"Surgery"},{"key":"ref_332","first-page":"16","article-title":"Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers","volume":"123","author":"Stolpen","year":"1986","journal-title":"Am. J. Pathol."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12974-016-0485-y","article-title":"Complement component c3a plays a critical role in endothelial activation and leukocyte recruitment into the brain","volume":"13","author":"Wu","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0002-9440(10)63173-2","article-title":"C5a-induced gene expression in human umbilical vein endothelial cells","volume":"164","author":"Albrecht","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2016.05.007","article-title":"Complement masp-1 enhances adhesion between endothelial cells and neutrophils by up-regulating e-selectin expression","volume":"75","author":"Jani","year":"2016","journal-title":"Mol. Immunol."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"107277","DOI":"10.1016\/j.vph.2024.107277","article-title":"COVID-19 plasma induces subcellular remodelling within the pulmonary microvascular endothelium","volume":"154","author":"Passi","year":"2024","journal-title":"Vasc. Pharmacol."},{"key":"ref_337","first-page":"10","article-title":"Relationship between COVID-19 severity, markers of endothelial impairment, and simple COVID risk index","volume":"132","author":"Fabis","year":"2022","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1182\/blood-2022-169506","article-title":"The complement system mediates COVID-19 endothelial cell injury, modifying cell permeability","volume":"140","author":"Bohorquez","year":"2022","journal-title":"Blood"},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/pai.13271","article-title":"The first, holistic immunological model of COVID-19: Implications for prevention, diagnosis, and public health measures","volume":"31","author":"Matricardi","year":"2020","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"108716","DOI":"10.1016\/j.clim.2021.108716","article-title":"Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19","volume":"226","author":"Satyam","year":"2021","journal-title":"Clin. Immunol."},{"key":"ref_341","doi-asserted-by":"crossref","unstructured":"Baena Carstens, L., Campos D\u2019amico, R., Fernandes de Moura, K., Morais de Castro, E., Centenaro, F., Silva Barbosa, G., Vieira Cavalcante da Silva, G., Brenny, I., Honorio D\u2019Agostini, J.C., and Hlatchuk, E.C. (2022). Lung inflammasome activation in SARS-CoV-2 post-mortem biopsies. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113033"},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00441-021-03471-2","article-title":"Endothelial cells and coagulation","volume":"387","author":"Neubauer","year":"2022","journal-title":"Cell Tissue Res."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12872-015-0124-z","article-title":"Endothelial cell control of thrombosis","volume":"15","author":"Yau","year":"2015","journal-title":"BMC Cardiovasc. Disord."},{"key":"ref_344","doi-asserted-by":"crossref","unstructured":"Brown, M.A., Stenberg, L.M., and Stenflo, J. (2013). Coagulation factor xa. Handb. Proteolytic Enzym., 2908.","DOI":"10.1016\/B978-0-12-382219-2.00642-6"},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"10212","DOI":"10.1073\/pnas.93.19.10212","article-title":"The endothelial cell protein c receptor augments protein c activation by the thrombin-thrombomodulin complex","volume":"93","author":"Kurosawa","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00277-023-05234-1","article-title":"Status of major hemostatic components in the setting of COVID-19: The effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement","volume":"102","author":"Sayyadi","year":"2023","journal-title":"Ann. Hematol."},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jbm.a.30222","article-title":"Procoagulant phenotype of endothelial cells after coculture with biomaterial-treated blood cells","volume":"72","author":"Rose","year":"2005","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2018-02-769000","article-title":"Inflammation, von willebrand factor, and adamts13","volume":"132","author":"Chen","year":"2018","journal-title":"Blood"},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/jth.15451","article-title":"Tissue factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients","volume":"19","author":"Subrahmanian","year":"2021","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"103812","DOI":"10.1016\/j.ebiom.2022.103812","article-title":"Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs","volume":"75","author":"Won","year":"2022","journal-title":"EBioMedicine"},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1084\/jem.163.3.740","article-title":"Modulation of endothelial cell hemostatic properties by tumor necrosis factor","volume":"163","author":"Nawroth","year":"1986","journal-title":"J. Exp. Med."},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1073\/pnas.83.10.3460","article-title":"Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity","volume":"83","author":"Nawroth","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"20705","DOI":"10.1016\/S0021-9258(19)47120-2","article-title":"Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor","volume":"264","author":"Scarpati","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V72.1.128.bloodjournal721128","article-title":"Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line u937 and peripheral blood monocytes","volume":"72","author":"Conkling","year":"1988","journal-title":"Blood"},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-5793(92)81139-D","article-title":"Il-4 inhibits lps-, il-1 beta- and tnf alpha-induced expression of tissue factor in endothelial cells and monocytes","volume":"310","author":"Herbert","year":"1992","journal-title":"FEBS Lett."},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0014-5793(93)80941-M","article-title":"Il-4 and il-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes","volume":"328","author":"Herbert","year":"1993","journal-title":"FEBS Lett."},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1055\/s-0038-1649721","article-title":"The effect of interleukin-4 on tumour necrosis factor-alpha induced expression of tissue factor and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells","volume":"70","author":"Martin","year":"1993","journal-title":"Thromb. Haemost."},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1182\/blood.V83.1.152.152","article-title":"Effect of human recombinant cytokines on the induction of macrophage procoagulant activity","volume":"83","author":"Schwager","year":"1994","journal-title":"Blood"},{"key":"ref_359","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1172\/JCI117202","article-title":"Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors","volume":"93","author":"Kirchhofer","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_360","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood.V84.8.2578.2578","article-title":"Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells","volume":"84","author":"Paleolog","year":"1994","journal-title":"Blood"},{"key":"ref_361","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1182\/blood.V86.1.250.bloodjournal861250","article-title":"Th1 and th2 t-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes","volume":"86","author":"Lammel","year":"1995","journal-title":"Blood"},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1006\/cyto.1996.0110","article-title":"Inhibition of il-1 induced tissue factor (tf) synthesis and procoagulant activity (pca) in purified human monocytes by il-4, il-10 and il-13","volume":"8","author":"Osnes","year":"1996","journal-title":"Cytokine"},{"key":"ref_363","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2141.1996.d01-1893.x","article-title":"Inhibition of tissue factor surface expression in human peripheral blood monocytes exposed to cytokines","volume":"95","author":"Ernofsson","year":"1996","journal-title":"Br. J. Haematol."},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"28568","DOI":"10.1074\/jbc.272.45.28568","article-title":"Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and thp-1 cells","volume":"272","author":"Schecter","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_365","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1161\/01.ATV.17.12.3399","article-title":"Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity","volume":"17","author":"Neumann","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_366","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1365-2141.1999.01782.x","article-title":"Leukaemia inhibitory factor enhances tissue factor expression in human monocyte-derived macrophages: A gp130-mediated mechanism","volume":"107","author":"Meisel","year":"1999","journal-title":"Br. J. Haematol."},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1128\/IAI.67.11.6130-6138.1999","article-title":"Bacterial species- and strain-dependent induction of tissue factor in human vascular endothelial cells","volume":"67","author":"Veltrop","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood.V77.3.542.542","article-title":"Regulation of thrombomodulin by tumor necrosis factor-alpha: Comparison of transcriptional and posttranscriptional mechanisms","volume":"77","author":"Lentz","year":"1991","journal-title":"Blood"},{"key":"ref_369","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V88.6.2043.bloodjournal8862043","article-title":"Regulation of thrombomodulin expression by all-trans retinoic acid and tumor necrosis factor-alpha: Differential responses in keratinocytes and endothelial cells","volume":"88","author":"Raife","year":"1996","journal-title":"Blood"},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"17499","DOI":"10.1074\/jbc.271.29.17499","article-title":"The endothelial cell protein c receptor. Inhibition of activated protein c anticoagulant function without modulation of reaction with proteinase inhibitors","volume":"271","author":"Regan","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.1074\/jbc.275.8.6038","article-title":"Metalloproteolytic release of endothelial cell protein c receptor","volume":"275","author":"Xu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_372","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/SHK.0000000000001780","article-title":"Could soluble endothelial protein c receptor levels recognize SARS-CoV2-positive patients requiring hospitalization?","volume":"56","author":"Vassiliou","year":"2021","journal-title":"Shock"},{"key":"ref_373","doi-asserted-by":"crossref","first-page":"26486","DOI":"10.1016\/S0021-9258(18)47220-1","article-title":"Identification, cloning, and regulation of a novel endothelial cell protein c\/activated protein c receptor","volume":"269","author":"Fukudome","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_374","doi-asserted-by":"crossref","first-page":"10396","DOI":"10.1016\/S0021-9258(18)81633-7","article-title":"Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha","volume":"264","author":"Sawdey","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1182\/blood.V75.10.1991.1991","article-title":"Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells","volume":"75","author":"Fiers","year":"1990","journal-title":"Blood"},{"key":"ref_376","first-page":"L47","article-title":"Increased secretion of urokinase-type plasminogen activator by human lung microvascular endothelial cells","volume":"275","author":"Takahashi","year":"1998","journal-title":"Am. J. Physiol."},{"key":"ref_377","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1016\/S0021-9258(18)60636-2","article-title":"Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor","volume":"263","author":"Schleef","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_378","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.4049\/jimmunol.157.6.2610","article-title":"Ifn-gamma inhibits thrombin- and endotoxin-induced plasminogen activator inhibitor type 1 in human endothelial cells","volume":"157","author":"Gallicchio","year":"1996","journal-title":"J. Immunol."},{"key":"ref_379","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0049-3848(95)93879-5","article-title":"Interferon-gamma modulates the fibrinolytic response in cultured human endothelial cells","volume":"77","author":"Arnman","year":"1995","journal-title":"Thromb. Res."},{"key":"ref_380","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/blood.V79.3.678.678","article-title":"Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by gamma-interferon","volume":"79","author":"Niedbala","year":"1992","journal-title":"Blood"},{"key":"ref_381","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1182\/blood.V81.12.3285.3285","article-title":"Interleukin-4 stimulates expression of urokinase-type-plasminogen activator in cultured human foreskin microvascular endothelial cells","volume":"81","author":"Wojta","year":"1993","journal-title":"Blood"},{"key":"ref_382","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1096\/fj.02-0737com","article-title":"Regulation by complement c3a and c5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells","volume":"17","author":"Monsinjon","year":"2003","journal-title":"FASEB J."},{"key":"ref_383","doi-asserted-by":"crossref","first-page":"e140966","DOI":"10.1172\/JCI140966","article-title":"Endothelial c3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging","volume":"131","author":"Propson","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_384","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1096\/fj.201902397R","article-title":"In response to complement anaphylatoxin peptides c3a and c5a, human vascular endothelial cells migrate and mediate the activation of b-cells and polarization of t-cells","volume":"34","author":"Shivshankar","year":"2020","journal-title":"FASEB J."},{"key":"ref_385","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0038-1655974","article-title":"C5a induces tissue factor activity on endothelial cells","volume":"77","author":"Ikeda","year":"1997","journal-title":"Thromb. Haemost."},{"key":"ref_386","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1016\/S0021-9258(18)81901-9","article-title":"Complement proteins c5b-9 induce secretion of high molecular weight multimers of endothelial von willebrand factor and translocation of granule membrane protein gmp-140 to the cell surface","volume":"264","author":"Hattori","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_387","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1016\/S0021-9258(19)39666-8","article-title":"Complement proteins c5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex","volume":"265","author":"Hamilton","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_388","doi-asserted-by":"crossref","first-page":"10948","DOI":"10.1073\/pnas.1707364114","article-title":"Complement-activation fragment c4a mediates effector functions by binding as untethered agonist to protease-activated receptors 1 and 4","volume":"114","author":"Wang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_389","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.4049\/jimmunol.0900879","article-title":"Complement protease masp-1 activates human endothelial cells: Par4 activation is a link between complement and endothelial function","volume":"183","author":"Megyeri","year":"2009","journal-title":"J. Immunol."},{"key":"ref_390","doi-asserted-by":"crossref","first-page":"918775","DOI":"10.3389\/fimmu.2022.918775","article-title":"Coagulation and complement: Key innate defense participants in a seamless web","volume":"13","author":"Pryzdial","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_391","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1134\/S0006297920100065","article-title":"Netosis: Molecular mechanisms, role in physiology and pathology","volume":"85","author":"Vorobjeva","year":"2020","journal-title":"Biochem. Biokhimiia"},{"key":"ref_392","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/nm.2847","article-title":"Infection-induced netosis is a dynamic process involving neutrophil multitasking in vivo","volume":"18","author":"Yipp","year":"2012","journal-title":"Nat. Med."},{"key":"ref_393","doi-asserted-by":"crossref","first-page":"11037","DOI":"10.1038\/ncomms11037","article-title":"Coagulation induced by c3ar-dependent netosis drives protumorigenic neutrophils during small intestinal tumorigenesis","volume":"7","author":"Guglietta","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_394","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","article-title":"Netosis, complement, and coagulation: A triangular relationship","volume":"16","author":"Boelens","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"ref_395","doi-asserted-by":"crossref","first-page":"44123","DOI":"10.1074\/jbc.M405883200","article-title":"Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation","volume":"279","author":"Martinelli","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_396","doi-asserted-by":"crossref","first-page":"e2122716119","DOI":"10.1073\/pnas.2122716119","article-title":"Neutrophils activated by membrane attack complexes increase the permeability of melanoma blood vessels","volume":"119","author":"Liu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_397","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/ATVBAHA.118.311150","article-title":"Neutrophil extracellular traps induce endothelial cell activation and tissue factor production through interleukin-1alpha and cathepsing","volume":"38","author":"Folco","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_398","doi-asserted-by":"crossref","first-page":"838011","DOI":"10.3389\/fimmu.2022.838011","article-title":"Netosis and neutrophil extracellular traps in COVID-19: Immunothrombosis and beyond","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_399","doi-asserted-by":"crossref","unstructured":"Ghanbari, E.P., Jakobs, K., Puccini, M., Reinshagen, L., Friebel, J., Haghikia, A., Krankel, N., Landmesser, U., and Rauch-Krohnert, U. (2023). The role of netosis and complement activation in COVID-19-associated coagulopathies. Biomedicines, 11.","DOI":"10.3390\/biomedicines11051371"},{"key":"ref_400","doi-asserted-by":"crossref","first-page":"15701","DOI":"10.1038\/s41598-021-95209-x","article-title":"Evolution of netosis markers and damps have prognostic value in critically ill COVID-19 patients","volume":"11","author":"Huckriede","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_401","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/jth.14888","article-title":"Incidence of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"Middeldorp","year":"2020","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_402","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"Lodigiani","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_403","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill icu patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_404","first-page":"e251","article-title":"Thromboembolic complications in covid-19 patients hospitalized in italian ordinary wards: Data from the multicenter observational start-covid register","volume":"6","author":"Poli","year":"2022","journal-title":"TH Open Companion J. Thromb. Haemost."},{"key":"ref_405","first-page":"236","article-title":"Hypercoagulability in COVID-19: From an unknown beginning to future therapies","volume":"95","author":"Duca","year":"2022","journal-title":"Med. Pharm. Rep."},{"key":"ref_406","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"Isth interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_407","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/ajh.25982","article-title":"Thrombosis in COVID-19","volume":"95","author":"Hanff","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_408","doi-asserted-by":"crossref","unstructured":"Chi, G., Lee, J.J., Jamil, A., Gunnam, V., Najafi, H., Memar Montazerin, S., Shojaei, F., and Marszalek, J. (2020). Venous thromboembolism among hospitalized patients with COVID-19 undergoing thromboprophylaxis: A systematic review and meta-analysis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082489"},{"key":"ref_409","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.thromres.2020.08.020","article-title":"Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis","volume":"196","author":"Porfidia","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_410","first-page":"e286","article-title":"Venous thromboembolism in hospitalized critical and noncritical COVID-19 patients: A systematic review and meta-analysis","volume":"5","author":"Mansory","year":"2021","journal-title":"TH Open Companion J. Thromb. Haemost."},{"key":"ref_411","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/jth.14869","article-title":"High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients","volume":"18","author":"Llitjos","year":"2020","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_412","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.120.047430","article-title":"Pulmonary embolism in patients with COVID-19: Awareness of an increased prevalence","volume":"142","author":"Poissy","year":"2020","journal-title":"Circulation"},{"key":"ref_413","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCULATIONAHA.120.047407","article-title":"Extremely high incidence of lower extremity deep venous thrombosis in 48 patients with severe COVID-19 in Wuhan","volume":"142","author":"Ren","year":"2020","journal-title":"Circulation"},{"key":"ref_414","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.chest.2020.11.005","article-title":"Incidence of vte and bleeding among hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis","volume":"159","author":"Jimenez","year":"2021","journal-title":"Chest"},{"key":"ref_415","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_416","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s11239-022-02766-7","article-title":"Risk of venous thromboembolic events after COVID-19 infection: A systematic review and meta-analysis","volume":"55","author":"Zuin","year":"2023","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_417","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13054-020-03077-0","article-title":"The unique characteristics of COVID-19 coagulopathy","volume":"24","author":"Iba","year":"2020","journal-title":"Crit. Care"},{"key":"ref_418","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_419","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_420","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/jth.14879","article-title":"What do monitoring platelet counts in COVID-19 teach us?","volume":"18","author":"Thachil","year":"2020","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_421","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/bjh.17656","article-title":"Immature platelets as a biomarker for disease severity and mortality in COVID-19 patients","volume":"194","author":"Welder","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_422","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s11239-021-02560-x","article-title":"Immature platelets in patients with COVID-19: Association with disease severity","volume":"52","author":"Cohen","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_423","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/09537104.2020.1852543","article-title":"Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure","volume":"32","author":"Campo","year":"2021","journal-title":"Platelets"},{"key":"ref_424","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/CIRCRESAHA.120.317703","article-title":"Platelets can associate with SARS-CoV-2 rna and are hyperactivated in COVID-19","volume":"127","author":"Zaid","year":"2020","journal-title":"Circ. Res."},{"key":"ref_425","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jacbts.2020.12.009","article-title":"Platelet and endothelial activation as potential mechanisms behind the thrombotic complications of COVID-19 patients","volume":"6","author":"Canzano","year":"2021","journal-title":"JACC Basic. Transl. Sci."},{"key":"ref_426","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/infdis\/jiaa756","article-title":"Association of neutrophil activation, more than platelet activation, with thrombotic complications in coronavirus disease 2019","volume":"223","author":"Petito","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_427","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19","volume":"136","author":"Hottz","year":"2020","journal-title":"Blood"},{"key":"ref_428","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"key":"ref_429","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s11239-021-02435-1","article-title":"Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: Evidence of inadequate therapy in a predominantly minority population","volume":"51","author":"Gurbel","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_430","doi-asserted-by":"crossref","first-page":"ofab274","DOI":"10.1093\/ofid\/ofab274","article-title":"First experience addressing the prognostic utility of novel urinary biomarkers in patients with COVID-19","volume":"8","author":"Tantry","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_431","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1161\/ATVBAHA.120.315175","article-title":"Platelets promote thromboinflammation in SARS-CoV-2 pneumonia","volume":"40","author":"Taus","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_432","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/bjh.17629","article-title":"Increased platelet activation in SARS-CoV-2 infected non-hospitalised children and adults, and their household contacts","volume":"195","author":"McCafferty","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_433","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/bjh.16749","article-title":"COVID19 coagulopathy in caucasian patients","volume":"189","author":"Fogarty","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_434","doi-asserted-by":"crossref","unstructured":"Ranucci, M., Sitzia, C., Baryshnikova, E., Di Dedda, U., Cardani, R., Martelli, F., and Corsi Romanelli, M. (2020). COVID-19-associated coagulopathy: Biomarkers of thrombin generation and fibrinolysis leading the outcome. J. Clin. Med., 9.","DOI":"10.21203\/rs.3.rs-52214\/v1"},{"key":"ref_435","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.1038\/s41598-021-85906-y","article-title":"Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients","volume":"11","author":"Minano","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_436","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1515\/cclm-2021-0108","article-title":"Thrombin generation in patients with COVID-19 with and without thromboprophylaxis","volume":"59","author":"Campello","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_437","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/ajh.25962","article-title":"Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19)","volume":"95","author":"Song","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_438","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1161\/ATVBAHA.120.314872","article-title":"Prevalence and outcomes of d-dimer elevation in hospitalized patients with COVID-19","volume":"40","author":"Berger","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_439","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jamcollsurg.2020.05.007","article-title":"Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection","volume":"231","author":"Wright","year":"2020","journal-title":"J. Am. Coll. Surg."},{"key":"ref_440","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11239-020-02226-0","article-title":"High d dimers and low global fibrinolysis coexist in COVID19 patients: What is going on in there?","volume":"51","author":"Ibanez","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_441","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bja.2020.12.010","article-title":"Impaired fibrinolysis in critically ill COVID-19 patients","volume":"126","author":"Bachler","year":"2021","journal-title":"Br. J. Anaesth."},{"key":"ref_442","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1055\/s-0040-1713637","article-title":"Fibrinolysis resistance: A potential mechanism underlying COVID-19 coagulopathy","volume":"120","author":"Weiss","year":"2020","journal-title":"Thromb. Haemost."},{"key":"ref_443","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/ALN.0000000000003685","article-title":"Greater fibrinolysis resistance but no greater platelet aggregation in critically ill COVID-19 patients","volume":"134","author":"Heinz","year":"2021","journal-title":"Anesthesiology"},{"key":"ref_444","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/jth.15016","article-title":"Hypofibrinolytic state and high thrombin generation may play a major role in SARS-CoV2 associated thrombosis","volume":"18","author":"Nougier","year":"2020","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_445","first-page":"1","article-title":"Plasminogen activator inhibitor-1 levels as an indicator of severity and mortality for COVID-19","volume":"10","author":"Baycan","year":"2023","journal-title":"North. Clin. Istanb."},{"key":"ref_446","first-page":"4764","article-title":"Evaluation of the relationship between tafi level and prognosis in COVID-19 patients","volume":"27","author":"Aksakal","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_447","doi-asserted-by":"crossref","unstructured":"Correa, T.D., Cordioli, R.L., Campos Guerra, J.C., Caldin da Silva, B., Dos Reis Rodrigues, R., de Souza, G.M., Midega, T.D., Campos, N.S., Carneiro, B.V., and Campos, F.N.D. (2020). Coagulation profile of COVID-19 patients admitted to the icu: An exploratory study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0243604"},{"key":"ref_448","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2021.12.012","article-title":"Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?","volume":"210","author":"Nielsen","year":"2022","journal-title":"Thromb. Res."},{"key":"ref_449","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/jth.14960","article-title":"Fibrinolysis and COVID-19: A plasmin paradox","volume":"18","author":"Medcalf","year":"2020","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_450","doi-asserted-by":"crossref","first-page":"664209","DOI":"10.3389\/fimmu.2021.664209","article-title":"Pulmonary procoagulant and innate immune responses in critically ill COVID-19 patients","volume":"12","author":"Nossent","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_451","doi-asserted-by":"crossref","first-page":"9060143","DOI":"10.1155\/2016\/9060143","article-title":"Platelet activation: The mechanisms and potential biomarkers","volume":"2016","author":"Yun","year":"2016","journal-title":"BioMed Res. Int."},{"key":"ref_452","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11239-021-02457-9","article-title":"Von willebrand factor and adamts13 activity as clinical severity markers in patients with COVID-19","volume":"52","author":"Marco","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_453","first-page":"O152","article-title":"Increased von willebrand factor antigen and low adamts13 activity are related to poor prognosis in COVID-19 patients","volume":"43","author":"Ayala","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_454","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/nep.14225","article-title":"COVID-19 associated thrombotic microangiopathy","volume":"28","author":"Cebi","year":"2023","journal-title":"Nephrology"},{"key":"ref_455","doi-asserted-by":"crossref","first-page":"148","DOI":"10.14740\/jh1019","article-title":"Coronavirus disease 2019-associated thrombotic microangiopathy","volume":"11","year":"2022","journal-title":"J. Hematol."},{"key":"ref_456","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1182\/blood.V86.5.1836.bloodjournal8651836","article-title":"Both tumor necrosis factor receptors, tnfr60 and tnfr80, are involved in signaling endothelial tissue factor expression by juxtacrine tumor necrosis factor alpha","volume":"86","author":"Schmid","year":"1995","journal-title":"Blood"},{"key":"ref_457","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1002\/eji.1830231048","article-title":"Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide","volume":"23","author":"Pradier","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"ref_458","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0014-5793(94)01236-9","article-title":"Interleukin-10 and pentoxifylline inhibit c-reactive protein-induced tissue factor gene expression in peripheral human blood monocytes","volume":"356","author":"Ramani","year":"1994","journal-title":"FEBS Lett."},{"key":"ref_459","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1182\/blood.V89.8.2701","article-title":"Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia","volume":"89","author":"Pajkrt","year":"1997","journal-title":"Blood"},{"key":"ref_460","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.4049\/jimmunol.158.4.1971","article-title":"Effects of il-10 on systemic inflammatory responses during sublethal primate endotoxemia","volume":"158","author":"Jansen","year":"1997","journal-title":"J. Immunol."},{"key":"ref_461","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1055\/s-0037-1614379","article-title":"Regulation of murine protein c gene expression in vivo: Effects of tumor necrosis factor-alpha, interleukin-1, and transforming growth factor-beta","volume":"82","author":"Yamamoto","year":"1999","journal-title":"Thromb. Haemost."},{"key":"ref_462","doi-asserted-by":"crossref","first-page":"19095","DOI":"10.1016\/S0021-9258(17)32279-2","article-title":"Induction of plasminogen activator inhibitor-1 in hepg2 human hepatoma cells by mediators of the acute phase response","volume":"269","author":"Healy","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_463","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0038-1647480","article-title":"Pai-1 synthesis in the human hepatoma cell line hepg2 is increased by cytokines--evidence that the liver contributes to acute phase behaviour of pai-1","volume":"65","author":"Abbink","year":"1991","journal-title":"Thromb. Haemost."},{"key":"ref_464","first-page":"186","article-title":"Urokinase and type i plasminogen activator inhibitor production by normal human hepatocytes: Modulation by inflammatory agents","volume":"20","author":"Busso","year":"1994","journal-title":"Hepatology"},{"key":"ref_465","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/(SICI)1097-4652(199609)168:3<648::AID-JCP17>3.0.CO;2-V","article-title":"Interleukin-1 induction of type-1 plasminogen activator inhibitor (pai-1) gene expression in the mouse hepatocyte line, aml 12","volume":"168","author":"Seki","year":"1996","journal-title":"J. Cell. Physiol."},{"key":"ref_466","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1182\/blood.V83.2.446.446","article-title":"Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees","volume":"83","author":"Levi","year":"1994","journal-title":"Blood"},{"key":"ref_467","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-0037-1615149","article-title":"Recombinant tumor necrosis factor receptor p75 fusion protein (tnfr:Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humans","volume":"80","author":"Stadnicki","year":"1998","journal-title":"Thromb. Haemost."},{"key":"ref_468","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1182\/blood.V86.3.1027.1027","article-title":"Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase a2 in sepsis: Studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia","volume":"86","author":"Jansen","year":"1995","journal-title":"Blood"},{"key":"ref_469","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2141.1992.tb06421.x","article-title":"Interleukin-2 induces activation of coagulation and fibrinolysis: Resemblance to the changes seen during experimental endotoxaemia","volume":"82","author":"Baars","year":"1992","journal-title":"Br. J. Haematol."},{"key":"ref_470","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1086\/314636","article-title":"Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees","volume":"179","author":"Lauw","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_471","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1055\/s-0038-1650653","article-title":"Interleukin-6 stimulates coagulation, not fibrinolysis, in humans","volume":"76","author":"Stouthard","year":"1996","journal-title":"Thromb. Haemost."},{"key":"ref_472","first-page":"236","article-title":"Thrombin and factor xa enhance the production of interleukin-1","volume":"71","author":"Jones","year":"1990","journal-title":"Immunology"},{"key":"ref_473","doi-asserted-by":"crossref","first-page":"895","DOI":"10.4049\/jimmunol.155.2.895","article-title":"Thrombin induces il-6 production in fibroblasts and epithelial cells. Evidence for the involvement of the seven-transmembrane domain (std) receptor for alpha-thrombin","volume":"155","author":"Sower","year":"1995","journal-title":"J. Immunol."},{"key":"ref_474","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood.V90.9.3595","article-title":"Fibrin regulation of interleukin-8 gene expression in human vascular endothelial cells","volume":"90","author":"Qi","year":"1997","journal-title":"Blood"},{"key":"ref_475","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.4049\/jimmunol.161.8.4318","article-title":"Factor xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells","volume":"161","author":"Senden","year":"1998","journal-title":"J. Immunol."},{"key":"ref_476","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1365-2567.1996.d01-635.x","article-title":"Thrombin stimulates production of interleukin-8 in human umbilical vein endothelial cells","volume":"88","author":"Ueno","year":"1996","journal-title":"Immunology"},{"key":"ref_477","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.4049\/jimmunol.159.11.5620","article-title":"Thrombin activates nuclear factor-kappab and potentiates endothelial cell activation by tnf","volume":"159","author":"Anrather","year":"1997","journal-title":"J. Immunol."},{"key":"ref_478","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1182\/blood.V87.12.5051.bloodjournal87125051","article-title":"The proinflammatory cytokine response to coagulation and endotoxin in whole blood","volume":"87","author":"Johnson","year":"1996","journal-title":"Blood"},{"key":"ref_479","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.4049\/jimmunol.160.10.5130","article-title":"Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation","volume":"160","author":"Johnson","year":"1998","journal-title":"J. Immunol."},{"key":"ref_480","first-page":"2302","article-title":"The anticoagulants protein c and protein s display potent antiinflammatory and immunosuppressive effects relevant to transplant biology and therapy","volume":"24","author":"Hancock","year":"1992","journal-title":"Transplant. Proc."},{"key":"ref_481","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.4049\/jimmunol.153.8.3664","article-title":"Selective inhibitory effects of the anticoagulant activated protein c on the responses of human mononuclear phagocytes to lps, ifn-gamma, or phorbol ester","volume":"153","author":"Grey","year":"1994","journal-title":"J. Immunol."},{"key":"ref_482","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1182\/blood.V87.2.642.bloodjournal872642","article-title":"Activated protein c attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats","volume":"87","author":"Murakami","year":"1996","journal-title":"Blood"},{"key":"ref_483","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1050-1738(97)00032-7","article-title":"Immunobiology and therapeutic applications of protein c\/protein s\/thrombomodulin in human and experimental allotransplantation and xenotransplantation","volume":"7","author":"Hancock","year":"1997","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_484","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood.V95.5.1680.005k33_1680_1686","article-title":"The endothelial cell protein c receptor aids in host defense against Escherichia coli sepsis","volume":"95","author":"Taylor","year":"2000","journal-title":"Blood"},{"key":"ref_485","first-page":"83","article-title":"Monocyte-macrophage release of il-1 is inhibited by type-1 plasminogen activator inhibitors","volume":"33","author":"Robson","year":"1990","journal-title":"J. Clin. Lab. Immunol."},{"key":"ref_486","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jlb.59.2.302","article-title":"Endogenously produced urokinase amplifies tumor necrosis factor-alpha secretion by thp-1 mononuclear phagocytes","volume":"59","author":"Sitrin","year":"1996","journal-title":"J. Leukoc. Biol."},{"key":"ref_487","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1089\/jir.1993.13.397","article-title":"U937 cells can utilize plasminogen activator to regulate human interferon-gamma","volume":"13","author":"Parmely","year":"1993","journal-title":"J. Interferon Res."},{"key":"ref_488","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1182\/blood.V91.5.1609","article-title":"Active site inhibited factor viia (degr viia) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to ld100 Escherichia coli","volume":"91","author":"Taylor","year":"1998","journal-title":"Blood"},{"key":"ref_489","first-page":"126","article-title":"Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock","volume":"44","author":"Carr","year":"1994","journal-title":"Circ. Shock."},{"key":"ref_490","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1172\/JCI112902","article-title":"Protein c prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon","volume":"79","author":"Taylor","year":"1987","journal-title":"J. Clin. Investig."},{"key":"ref_491","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1182\/blood.V78.2.357.357","article-title":"C4b-binding protein exacerbates the host response to Escherichia coli","volume":"78","author":"Taylor","year":"1991","journal-title":"Blood"},{"key":"ref_492","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1172\/JCI116529","article-title":"Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock","volume":"91","author":"Creasey","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_493","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MBC.0000000000000720","article-title":"Complement-coagulation connections","volume":"29","author":"Conway","year":"2018","journal-title":"Blood Coagul. Fibrinolysis Int. J. Haemost. Thromb."},{"key":"ref_494","doi-asserted-by":"crossref","first-page":"103529","DOI":"10.1016\/j.critrevonc.2021.103529","article-title":"COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications","volume":"168","author":"Lim","year":"2021","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_495","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1111\/jth.14981","article-title":"COVID-19: A collision of complement, coagulation and inflammatory pathways","volume":"18","author":"Chauhan","year":"2020","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_496","doi-asserted-by":"crossref","first-page":"716361","DOI":"10.3389\/fimmu.2021.716361","article-title":"Thromboinflammation supports complement activation in cancer patients with COVID-19","volume":"12","author":"Peerschke","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_497","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41591-020-1021-2","article-title":"Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection","volume":"26","author":"Ramlall","year":"2020","journal-title":"Nat. Med."},{"key":"ref_498","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1182\/blood-2022-166296","article-title":"Thrombomodulin resistance may be involved in the prothrombotic state of COVID-19","volume":"140","author":"Marco","year":"2022","journal-title":"Blood"},{"key":"ref_499","doi-asserted-by":"crossref","first-page":"21493","DOI":"10.1038\/s41598-023-48633-0","article-title":"Variation in presepsin and thrombomodulin levels for predicting COVID-19 mortality","volume":"13","author":"Yamazaki","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_500","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41419-021-04070-3","article-title":"Low level of plasminogen increases risk for mortality in COVID-19 patients","volume":"12","author":"Pacifici","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_501","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1161\/CIRCULATIONAHA.120.050656","article-title":"Neutrophils and contact activation of coagulation as potential drivers of COVID-19","volume":"142","author":"Busch","year":"2020","journal-title":"Circulation"},{"key":"ref_502","doi-asserted-by":"crossref","first-page":"767347","DOI":"10.3389\/fimmu.2021.767347","article-title":"SARS-CoV-2 exacerbates COVID-19 pathology through activation of the complement and kinin systems","volume":"12","author":"Savitt","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_503","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bcmd.2005.12.016","article-title":"Collagen-induced platelet activation","volume":"36","author":"Farndale","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_504","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1538-7836.2009.03378.x","article-title":"The structure and function of platelet integrins","volume":"7","author":"Bennett","year":"2009","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_505","doi-asserted-by":"crossref","first-page":"4A","DOI":"10.1016\/j.amjcard.2008.11.017","article-title":"Role of platelets in atherothrombosis","volume":"103","author":"Jennings","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_506","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/10409239709082000","article-title":"Adp-induced platelet activation","volume":"32","author":"Puri","year":"1997","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_507","doi-asserted-by":"crossref","unstructured":"Martel, C., Cointe, S., Maurice, P., Matar, S., Ghitescu, M., Theroux, P., and Bonnefoy, A. (2011). Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018812"},{"key":"ref_508","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00911092","article-title":"Comparative study on biological activities of various anaphylatoxins (c4a, c3a, c5a). Investigations on their ability to induce platelet secretion","volume":"5","author":"Meuer","year":"1981","journal-title":"Inflammation"},{"key":"ref_509","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1084\/jem.158.2.603","article-title":"Human platelet activation by c3a and c3a des-arg","volume":"158","author":"Polley","year":"1983","journal-title":"J. Exp. Med."},{"key":"ref_510","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1182\/bloodadvances.2021005246","article-title":"C5a and c5ar1 are key drivers of microvascular platelet aggregation in clinical entities spanning from ahus to COVID-19","volume":"6","author":"Aiello","year":"2022","journal-title":"Blood Adv."},{"key":"ref_511","doi-asserted-by":"crossref","first-page":"236","DOI":"10.12688\/f1000research.13283.1","article-title":"The life cycle of platelet granules","volume":"7","author":"Sharda","year":"2018","journal-title":"F1000Research"},{"key":"ref_512","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3389\/fimmu.2019.01590","article-title":"The human platelet as an innate immune cell: Interactions between activated platelets and the complement system","volume":"10","author":"Eriksson","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_513","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.blre.2014.10.003","article-title":"Platelet secretion: From haemostasis to wound healing and beyond","volume":"29","author":"Golebiewska","year":"2015","journal-title":"Blood Rev."},{"key":"ref_514","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.phrs.2018.06.015","article-title":"Beyond a neurotransmitter: The role of serotonin in inflammation and immunity","volume":"140","author":"Wu","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_515","doi-asserted-by":"crossref","first-page":"9524075","DOI":"10.1155\/2018\/9524075","article-title":"Role of histamine in modulating the immune response and inflammation","volume":"2018","author":"Branco","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_516","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molimm.2015.03.244","article-title":"Complement and platelets: Mutual interference in the immune network","volume":"67","author":"Speth","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_517","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1084\/jem.20041497","article-title":"Platelet activation leads to activation and propagation of the complement system","volume":"201","author":"Cruz","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_518","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.molimm.2006.11.012","article-title":"Classical pathway complement activation on human endothelial cells","volume":"44","author":"Yin","year":"2007","journal-title":"Mol. Immunol."},{"key":"ref_519","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1538-7836.2008.03034.x","article-title":"Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets","volume":"6","author":"Hamad","year":"2008","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_520","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.imbio.2009.11.004","article-title":"C1q induces a rapid up-regulation of p-selectin and modulates collagen- and collagen-related peptide-triggered activation in human platelets","volume":"215","author":"Skoglund","year":"2010","journal-title":"Immunobiology"},{"key":"ref_521","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.4049\/jimmunol.0902810","article-title":"Complement component c3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1","volume":"184","author":"Hamad","year":"2010","journal-title":"J. Immunol."},{"key":"ref_522","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.4049\/jimmunol.1300610","article-title":"Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O)","volume":"190","author":"Saggu","year":"2013","journal-title":"J. Immunol."},{"key":"ref_523","doi-asserted-by":"crossref","first-page":"402783","DOI":"10.6064\/2012\/402783","article-title":"Complement activation: An emerging player in the pathogenesis of cardiovascular disease","volume":"2012","author":"Carter","year":"2012","journal-title":"Scientifica"},{"key":"ref_524","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/blood.V68.4.875.875","article-title":"Complement proteins c5b-9 stimulate procoagulant activity through platelet prothrombinase","volume":"68","author":"Wiedmer","year":"1986","journal-title":"Blood"},{"key":"ref_525","doi-asserted-by":"crossref","first-page":"18205","DOI":"10.1016\/S0021-9258(19)81346-7","article-title":"Complement proteins c5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor va and express prothrombinase activity","volume":"263","author":"Sims","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_526","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/09537100701777311","article-title":"Expression of complement components and inhibitors on platelet microparticles","volume":"19","author":"Yin","year":"2008","journal-title":"Platelets"},{"key":"ref_527","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.intimp.2007.07.006","article-title":"The role of the complement anaphylatoxins in the recruitment of eosinophils","volume":"7","author":"DiScipio","year":"2007","journal-title":"Int. Immunopharmacol."},{"key":"ref_528","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1016\/j.cell.2023.09.020","article-title":"Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors","volume":"186","author":"Yadav","year":"2023","journal-title":"Cell"},{"key":"ref_529","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.imbio.2011.07.016","article-title":"The new face of anaphylatoxins in immune regulation","volume":"217","author":"Zhou","year":"2012","journal-title":"Immunobiology"},{"key":"ref_530","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.177.7.4794","article-title":"A novel c5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways","volume":"177","author":"Ritis","year":"2006","journal-title":"J. Immunol."},{"key":"ref_531","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/s41598-021-81268-7","article-title":"Neutrophils can promote clotting via fxi and impact clot structure via neutrophil extracellular traps in a distinctive manner in vitro","volume":"11","author":"Shi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_532","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood-2013-10-463646","article-title":"Thrombosis: Tangled up in nets","volume":"123","author":"Martinod","year":"2014","journal-title":"Blood"},{"key":"ref_533","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo","volume":"209","author":"Stark","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_534","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fimmu.2016.00137","article-title":"Netosing neutrophils activate complement both on their own nets and bacteria via alternative and non-alternative pathways","volume":"7","author":"Yuen","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_535","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1074\/jbc.M211956200","article-title":"Neutrophil cathepsin g promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets","volume":"278","author":"Goel","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_536","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0741-5214(94)70106-7","article-title":"Human neutrophil cathepsin g is a potent platelet activator","volume":"19","author":"LaRosa","year":"1994","journal-title":"J. Vasc. Surg."},{"key":"ref_537","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood.V82.1.139.bloodjournal821139","article-title":"Enhancement of cathepsin g-induced platelet activation by leukocyte elastase: Consequence for the neutrophil-mediated platelet activation","volume":"82","author":"Renesto","year":"1993","journal-title":"Blood"},{"key":"ref_538","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1074\/jbc.270.3.1408","article-title":"Human coagulation factor v is activated to the functional cofactor by elastase and cathepsin g expressed at the monocyte surface","volume":"270","author":"Allen","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_539","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1160\/TH07-08-0495","article-title":"Cathepsin g, a leukocyte protease, activates coagulation factor viii","volume":"99","author":"Gale","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_540","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1042\/bj3190873","article-title":"Activation of mac-1 (cd11b\/cd18)-bound factor x by released cathepsin g defines an alternative pathway of leucocyte initiation of coagulation","volume":"319","author":"Plescia","year":"1996","journal-title":"Biochem. J."},{"key":"ref_541","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-0038-1648489","article-title":"Effect of leukocyte proteinases on tissue factor pathway inhibitor","volume":"67","author":"Petersen","year":"1992","journal-title":"Thromb. Haemost."},{"key":"ref_542","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1515\/bchm2.1981.362.1.103","article-title":"Effect of human granulocytic elastase on isolated human antithrombin iii","volume":"362","author":"Jochum","year":"1981","journal-title":"Hoppe-Seyler\u2019s Z. Fur Physiol. Chem."},{"key":"ref_543","doi-asserted-by":"crossref","first-page":"108598","DOI":"10.1016\/j.clim.2020.108598","article-title":"Complement c3 vs c5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy","volume":"220","author":"Mastellos","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_544","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood.V100.2.517","article-title":"C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils","volume":"100","author":"Wojta","year":"2002","journal-title":"Blood"},{"key":"ref_545","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000083842","article-title":"New aspects in thrombotic research: Complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotype","volume":"33","author":"Wojta","year":"2003","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"ref_546","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.4049\/jimmunol.1302484","article-title":"Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release","volume":"192","author":"Samstad","year":"2014","journal-title":"J. Immunol."},{"key":"ref_547","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.thromres.2022.04.001","article-title":"Nlrp3 inflammasome contributes to endotoxin-induced coagulation","volume":"214","author":"Shi","year":"2022","journal-title":"Thromb. Res."},{"key":"ref_548","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2567.2009.03200.x","article-title":"Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot","volume":"129","author":"Gulla","year":"2010","journal-title":"Immunology"},{"key":"ref_549","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.molimm.2015.02.014","article-title":"Masp-1 of the complement system promotes clotting via prothrombin activation","volume":"65","author":"Jenny","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_550","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.bbapap.2008.03.020","article-title":"The action of mbl-associated serine protease 1 (masp1) on factor xiii and fibrinogen","volume":"1784","author":"Krarup","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_551","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/1479164111432788","article-title":"Complement c3 is a novel plasma clot component with anti-fibrinolytic properties","volume":"9","author":"Howes","year":"2012","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_552","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1160\/TH09-02-0103","article-title":"Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction","volume":"102","author":"Distelmaier","year":"2009","journal-title":"Thromb. Haemost."},{"key":"ref_553","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bjh.12096","article-title":"Complement c3 is a substrate for activated factor xiii that is cross-linked to fibrin during clot formation","volume":"160","author":"Richardson","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_554","doi-asserted-by":"crossref","first-page":"152707","DOI":"10.1016\/j.imbio.2023.152707","article-title":"Complement and coagulation crosstalk\u2014Factor h in the spotlight","volume":"228","author":"Heurich","year":"2023","journal-title":"Immunobiology"},{"key":"ref_555","doi-asserted-by":"crossref","first-page":"40880","DOI":"10.1074\/jbc.M105934200","article-title":"Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2","volume":"276","author":"Rossi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_556","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1160\/TH04-01-0008","article-title":"Inhibition of plasma kallikrein by c1-inhibitor: Role of endothelial cells and the amino-terminal domain of c1-inhibitor","volume":"92","author":"Ravindran","year":"2004","journal-title":"Thromb. Haemost."},{"key":"ref_557","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular intercommunication between the complement and coagulation systems","volume":"185","author":"Amara","year":"2010","journal-title":"J. Immunol."},{"key":"ref_558","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.molimm.2007.07.008","article-title":"Elucidation of the substrate specificity of the masp-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, c1-inhibitor","volume":"45","author":"Kerr","year":"2008","journal-title":"Mol. Immunol."},{"key":"ref_559","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0065-2776(08)60417-4","article-title":"Some relationships among hemostasis, fibrinolytic phenomena, immunity, and the inflammatory response","volume":"10","author":"Ratnoff","year":"1969","journal-title":"Adv. Immunol."},{"key":"ref_560","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0049-3848(85)90182-3","article-title":"Activation of factor b of the complement system by kallikrein and its light chain","volume":"38","author":"Hiemstra","year":"1985","journal-title":"Thromb. Res."},{"key":"ref_561","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000484257","article-title":"Kallikrein cleaves c3 and activates complement","volume":"10","author":"Irmscher","year":"2018","journal-title":"J. Innate Immun."},{"key":"ref_562","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1172\/JCI110898","article-title":"Mechanisms of activation of the classical pathway of complement by hageman factor fragment","volume":"71","author":"Ghebrehiwet","year":"1983","journal-title":"J. Clin. Investig."},{"key":"ref_563","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ebiom.2016.02.011","article-title":"Complement activation in arterial and venous thrombosis is mediated by plasmin","volume":"5","author":"Foley","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_564","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1084\/jem.147.6.1713","article-title":"The human complement system in thrombin-mediated platelet function","volume":"147","author":"Polley","year":"1978","journal-title":"J. Exp. Med."},{"key":"ref_565","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.150.3.633","article-title":"Human complement in thrombin-mediated platelet function: Uptake of the c5b-9 complex","volume":"150","author":"Polley","year":"1979","journal-title":"J. Exp. Med."},{"key":"ref_566","doi-asserted-by":"crossref","first-page":"31877","DOI":"10.1038\/srep31877","article-title":"Masp-3 is the exclusive pro-factor d activator in resting blood: The lectin and the alternative complement pathways are fundamentally linked","volume":"6","author":"Dobo","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_567","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4049\/jimmunol.1501717","article-title":"Masp-1 and masp-2 do not activate pro-factor d in resting human blood, whereas masp-3 is a potential activator: Kinetic analysis involving specific masp-1 and masp-2 inhibitors","volume":"196","author":"Oroszlan","year":"2016","journal-title":"J. Immunol."},{"key":"ref_568","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2012-02-412080","article-title":"Thrombin generates previously unidentified c5 products that support the terminal complement activation pathway","volume":"120","author":"Krisinger","year":"2012","journal-title":"Blood"},{"key":"ref_569","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5582\/bst.2016.01052","article-title":"Dual modulating functions of thrombomodulin in the alternative complement pathway","volume":"10","author":"Tateishi","year":"2016","journal-title":"Biosci. Trends"},{"key":"ref_570","doi-asserted-by":"crossref","first-page":"18831","DOI":"10.1074\/jbc.M111.323287","article-title":"Plasminogen is a complement inhibitor","volume":"287","author":"Barthel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_571","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood.V96.8.2784","article-title":"Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase c-dependent pathway protects vascular endothelial cells from complement-mediated injury","volume":"96","author":"Lidington","year":"2000","journal-title":"Blood"},{"key":"ref_572","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0167-4838(82)90307-7","article-title":"Inhibition of human factor xa by various plasma protease inhibitors","volume":"701","author":"Ellis","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_573","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-0038-1647922","article-title":"The effect of antithrombin iii on the activity of the coagulation factors vii, ix and x","volume":"35","author":"Osterud","year":"1976","journal-title":"Thromb. Haemost."},{"key":"ref_574","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.molimm.2013.01.009","article-title":"The control of the complement lectin pathway activation revisited: Both c1-inhibitor and antithrombin are likely physiological inhibitors, while alpha2-macroglobulin is not","volume":"54","author":"Parej","year":"2013","journal-title":"Mol. Immunol."},{"key":"ref_575","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/jth.15697","article-title":"Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy","volume":"20","author":"Mast","year":"2022","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_576","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.thromres.2010.01.038","article-title":"Alternatively spliced isoforms of tissue factor pathway inhibitor","volume":"125","author":"Maroney","year":"2010","journal-title":"Thromb. Res."},{"key":"ref_577","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/ATVBAHA.115.305996","article-title":"Tissue factor pathway inhibitor: Multiple anticoagulant activities for a single protein","volume":"36","author":"Mast","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_578","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/eji.201445070","article-title":"Tfpi inhibits lectin pathway of complement activation by direct interaction with masp-2","volume":"45","author":"Keizer","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"ref_579","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1348-0421.2002.tb02669.x","article-title":"Inactivation of c3a and c5a octapeptides by carboxypeptidase r and carboxypeptidasen","volume":"46","author":"Campbell","year":"2002","journal-title":"Microbiol. Immunol."},{"key":"ref_580","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1016\/j.molimm.2008.07.010","article-title":"Regulation of tissue inflammation by thrombin-activatable carboxypeptidase b (or tafi)","volume":"45","author":"Leung","year":"2008","journal-title":"Mol. Immunol."},{"key":"ref_581","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_582","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.thromres.2016.07.017","article-title":"Thrombomodulin enhances complement regulation through strong affinity interactions with factor h and c3b-factor h complex","volume":"145","author":"Heurich","year":"2016","journal-title":"Thromb. Res."},{"key":"ref_583","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.4049\/jimmunol.2000398","article-title":"Cross-talk between the complement pathway and the contact activation system of coagulation: Activated factor xi neutralizes complement factor h","volume":"206","author":"Puy","year":"2021","journal-title":"J. Immunol."},{"key":"ref_584","first-page":"1536","article-title":"Association of complement factor h polymorphisms with exudative age-related macular degeneration","volume":"12","author":"Chen","year":"2006","journal-title":"Mol. Vis."},{"key":"ref_585","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/jth.14742","article-title":"Contact activation-induced complex formation between complement factor h and coagulation factor xiia","volume":"18","author":"Thangaraj","year":"2020","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_586","doi-asserted-by":"crossref","unstructured":"Feng, S., Liang, X., Cruz, M.A., Vu, H., Zhou, Z., Pemmaraju, N., Dong, J.F., Kroll, M.H., and Afshar-Kharghan, V. (2013). The interaction between factor h and von willebrand factor. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073715"},{"key":"ref_587","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1161\/ATVBAHA.113.302280","article-title":"Human complement factor h is a reductase for large soluble von willebrand factor multimers--brief report","volume":"33","author":"Nolasco","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_588","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood-2013-04-495853","article-title":"The interaction between factor h and vwf increases factor h cofactor activity and regulates vwf prothrombotic status","volume":"123","author":"Rayes","year":"2014","journal-title":"Blood"},{"key":"ref_589","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-0034-1383547","article-title":"Thrombotic microangiopathies and the linkage between von willebrand factor and the alternative complement pathway","volume":"40","author":"Turner","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_590","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1182\/blood-2014-06-585430","article-title":"Von willebrand factor is a cofactor in complement regulation","volume":"125","author":"Feng","year":"2015","journal-title":"Blood"},{"key":"ref_591","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1182\/blood-2016-11-749879","article-title":"Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development","volume":"129","author":"Subramaniam","year":"2017","journal-title":"Blood"},{"key":"ref_592","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molimm.2014.05.013","article-title":"Multiple roles of complement masp-1 at the interface of innate immune response and coagulation","volume":"61","author":"Dobo","year":"2014","journal-title":"Mol. Immunol."},{"key":"ref_593","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.imbio.2010.02.005","article-title":"Mannose-binding lectin and its associated proteases (masps) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation","volume":"216","author":"Takahashi","year":"2011","journal-title":"Immunobiology"},{"key":"ref_594","doi-asserted-by":"crossref","first-page":"117232","DOI":"10.1016\/j.carbpol.2020.117232","article-title":"Comprehensive landscape of heparin therapy for COVID-19","volume":"254","author":"Shi","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"ref_595","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/22221751.2020.1746199","article-title":"Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia","volume":"9","author":"Lin","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_596","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5582\/bst.2022.01225","article-title":"Heparin therapy in COVID-19: Call for randomized controlled trials (rcts)","volume":"16","author":"Fang","year":"2022","journal-title":"Biosci. Trends"},{"key":"ref_597","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s00392-023-02240-1","article-title":"Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: Results of the COVID-prevent randomized controlled trial","volume":"112","author":"Puccini","year":"2023","journal-title":"Clin. Res. Cardiol."},{"key":"ref_598","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMoa1805090","article-title":"Rivaroxaban for thromboprophylaxis after hospitalization for medical illness","volume":"379","author":"Spyropoulos","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_599","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.jacc.2020.04.071","article-title":"Post-discharge prophylaxis with rivaroxaban reduces fatal and major thromboembolic events in medically ill patients","volume":"75","author":"Spyropoulos","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_600","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41423-023-01104-y","article-title":"SARS-CoV-2 and innate immunity: The good, the bad, and the \u201cgoldilocks\u201d","volume":"21","author":"Sievers","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"ref_601","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molimm.2023.03.009","article-title":"Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2","volume":"156","author":"Purbey","year":"2023","journal-title":"Mol. Immunol."},{"key":"ref_602","doi-asserted-by":"crossref","unstructured":"WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne, J.A.C., Murthy, S., Diaz, J.V., Slutsky, A.S., Villar, J., Angus, D.C., Annane, D., Azevedo, L.C.P., and Berwanger, O. (2020). Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: A meta-analysis. JAMA, 324, 1330\u20131341.","DOI":"10.1001\/jama.2020.17023"},{"key":"ref_603","doi-asserted-by":"crossref","first-page":"109161","DOI":"10.1016\/j.intimp.2022.109161","article-title":"Targeted therapy in coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine","volume":"111","author":"Shirzad","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_604","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group, Horby, P., Lim, W.S., Emberson, J.R., Mafham, M., Bell, J.L., Linsell, L., Staplin, N., Brightling, C., and Ustianowski, A. (2021). Dexamethasone in hospitalized patients with COVID-19. N. Engl. J. Med., 384, 693\u2013704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"ref_605","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group (2022). Baricitinib in patients admitted to hospital with COVID-19 (recovery): A randomised, controlled, open-label, platform trial and updated meta-analysis. Lancet, 400, 359\u2013368.","DOI":"10.1101\/2022.03.02.22271623"},{"key":"ref_606","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S2213-2600(22)00006-6","article-title":"Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: An exploratory, randomised, placebo-controlled trial","volume":"10","author":"Ely","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_607","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S2213-2600(21)00331-3","article-title":"Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (cov-barrier): A randomised, double-blind, parallel-group, placebo-controlled phase 3 trial","volume":"9","author":"Marconi","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_608","unstructured":"WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Shankar-Hari, M., Vale, C.L., Godolphin, P.J., Fisher, D., Higgins, J.P.T., Spiga, F., Savovic, J., Tierney, J., and Baron, G. (2021). Association between administration of il-6 antagonists and mortality among patients hospitalized for COVID-19: A meta-analysis. JAMA, 326, 499\u2013518."},{"key":"ref_609","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41581-022-00642-4","article-title":"Therapeutic advances in COVID-19","volume":"19","author":"Murakami","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_610","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0140-6736(23)00587-1","article-title":"Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?","volume":"401","author":"Perner","year":"2023","journal-title":"Lancet"},{"key":"ref_611","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa2209421","article-title":"Inhaled fluticasone furoate for outpatient treatment of COVID-19","volume":"389","author":"Boulware","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_612","doi-asserted-by":"crossref","first-page":"e075803","DOI":"10.1136\/bmjopen-2023-075803","article-title":"Inhaled beclomethasone in the treatment of early COVID-19: A double-blind, placebo-controlled, randomised, hospital-based trial in sri lanka","volume":"13","author":"Mettananda","year":"2023","journal-title":"BMJ Open"},{"key":"ref_613","doi-asserted-by":"crossref","first-page":"102960","DOI":"10.1016\/j.arcmed.2024.102960","article-title":"Intranasal versus intravenous dexamethasone to treat hospitalized COVID-19 patients: A randomized multicenter clinical trial","volume":"55","author":"Cardenas","year":"2024","journal-title":"Arch. Med. Res."},{"key":"ref_614","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10787-020-00732-4","article-title":"Empagliflozin suppresses inflammation and protects against acute septic renal injury","volume":"29","author":"Maayah","year":"2021","journal-title":"Inflammopharmacology"},{"key":"ref_615","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.diabet.2018.09.005","article-title":"Effects of sglt2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease","volume":"44","author":"Bonnet","year":"2018","journal-title":"Diabetes Metab."},{"key":"ref_616","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","article-title":"Sglt2 inhibition modulates nlrp3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_617","doi-asserted-by":"crossref","unstructured":"Chang, Y.S., Ko, B.H., Ju, J.C., Chang, H.H., Huang, S.H., and Lin, C.W. (2020). Sars unique domain (sud) of severe acute respiratory syndrome coronavirus induces nlrp3 inflammasome-dependent cxcl10-mediated pulmonary inflammation. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093179"},{"key":"ref_618","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1093\/ehjcvp\/pvaa098","article-title":"The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: An observational study","volume":"7","author":"Dalan","year":"2021","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_619","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S2213-8587(21)00180-7","article-title":"Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (dare-19): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Kosiborod","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_620","unstructured":"RECOVERY Collaborative Group (2023). Empagliflozin in patients admitted to hospital with COVID-19 (recovery): A randomised, controlled, open-label, platform trial. Lancet Diabetes Endocrinol., 11, 905\u2013914."},{"key":"ref_621","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1038\/s41467-020-18764-3","article-title":"SARS-CoV2-mediated suppression of nrf2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate","volume":"11","author":"Olagnier","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_622","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group, Horby, P.W., Peto, L., Staplin, N., Campbell, M., Pessoa-Amorim, G., Mafham, M., Emberson, J.R., Stewart, R., and Prudon, B. (2024). Dimethyl fumarate in patients admitted to hospital with COVID-19 (recovery): A randomised, controlled, open-label, platform trial. Nat. Commun., 15, 924.","DOI":"10.1038\/s41467-023-43644-x"},{"key":"ref_623","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1111\/cts.13658","article-title":"Enpatoran in COVID-19 pneumonia: Safety and efficacy results from a phase ii randomized trial","volume":"16","author":"McKinnon","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"ref_624","doi-asserted-by":"crossref","first-page":"107168","DOI":"10.1016\/j.ijid.2024.107168","article-title":"Efficacy of infliximab, abatacept, and cenicriviroc for the treatment of adults hospitalized with COVID-19 pneumonia","volume":"146","author":"Lin","year":"2024","journal-title":"Int. J. Infect. Dis. IJID"},{"key":"ref_625","doi-asserted-by":"crossref","unstructured":"Piscoya, A., Parra Del Riego, A., Cerna-Viacava, R., Rocco, J., Roman, Y.M., Escobedo, A.A., Pasupuleti, V., White, C.M., and Hernandez, A.V. (2022). Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0269368"},{"key":"ref_626","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1056\/NEJMoa2028836","article-title":"Efficacy of tocilizumab in patients hospitalized with COVID-19","volume":"383","author":"Stone","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_627","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jamainternmed.2020.6615","article-title":"Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: A randomized clinical trial","volume":"181","author":"Salvarani","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"ref_628","doi-asserted-by":"crossref","first-page":"101489","DOI":"10.1016\/j.eclinm.2022.101489","article-title":"Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trials","volume":"49","author":"Selvaraj","year":"2022","journal-title":"EClinicalMedicine"},{"key":"ref_629","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1093\/rheumatology\/keab447","article-title":"Anakinra in hospitalized non-intubated patients with coronavirus disease 2019: A systematic review and meta-analysis","volume":"60","author":"Barkas","year":"2021","journal-title":"Rheumatology"},{"key":"ref_630","doi-asserted-by":"crossref","first-page":"155544","DOI":"10.1016\/j.cyto.2021.155544","article-title":"Perspectives on anti-il-1 inhibitors as potential therapeutic interventions for severe COVID-19","volume":"143","author":"Geng","year":"2021","journal-title":"Cytokine"},{"key":"ref_631","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/s41591-021-01569-2","article-title":"Author correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: A double-blind, randomized controlled phase 3 trial","volume":"27","author":"Kyriazopoulou","year":"2021","journal-title":"Nat. Med."},{"key":"ref_632","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1016\/S2665-9913(21)00216-2","article-title":"Effect of anakinra on mortality in patients with COVID-19: A systematic review and patient-level meta-analysis","volume":"3","author":"Kyriazopoulou","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"ref_633","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: A retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"ref_634","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ijid.2020.11.149","article-title":"Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study","volume":"103","author":"Balkhair","year":"2021","journal-title":"Int. J. Infect. Dis. IJID"},{"key":"ref_635","doi-asserted-by":"crossref","first-page":"e66125","DOI":"10.7554\/eLife.66125","article-title":"An open label trial of anakinra to prevent respiratory failure in COVID-19","volume":"10","author":"Kyriazopoulou","year":"2021","journal-title":"Elife"},{"key":"ref_636","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/iid3.563","article-title":"A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID-19","volume":"10","author":"Kharazmi","year":"2022","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_637","doi-asserted-by":"crossref","unstructured":"Jackson, L.E., Khullar, N., Beukelman, T., Chapleau, C., Kamath, A., Cron, R.Q., and Chatham, W.W. (2023). Prediction of survival by il-6 in a randomized placebo-controlled trial of anakinra in COVID-19 cytokine storm. Viruses, 15.","DOI":"10.3390\/v15102036"},{"key":"ref_638","unstructured":"The CORIMUNO-19 Collaborative group (2021). Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (corimuno-ana-1): A randomised controlled trial. Lancet Respir. Med., 9, 295\u2013304."},{"key":"ref_639","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S2213-2600(23)00376-4","article-title":"Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (tactic-r): A randomised, parallel-arm, open-label, phase 4 trial","volume":"11","author":"Hall","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"ref_640","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S2213-2600(23)00082-6","article-title":"Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: A phase 3, multicentre, open-label, randomised controlled trial","volume":"11","author":"Annane","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"ref_641","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S2213-2600(22)00297-1","article-title":"Anti-c5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (panamo): A multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"10","author":"Vlaar","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_642","doi-asserted-by":"crossref","first-page":"e2142796","DOI":"10.1001\/jamanetworkopen.2021.42796","article-title":"Trajectory of viral rna load among persons with incident SARS-CoV-2 g614 infection (wuhan strain) in association with COVID-19 symptom onset and severity","volume":"5","author":"Dong","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_643","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa2209760","article-title":"Early treatment with pegylated interferon lambda for COVID-19","volume":"388","author":"Reis","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_644","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1186\/s12879-024-09576-7","article-title":"Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals, or no treatment: A retrospective cohort study","volume":"24","author":"Drysdale","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"ref_645","first-page":"CD014962","article-title":"Remdesivir for the treatment of COVID-19","volume":"1","author":"Grundeis","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_646","doi-asserted-by":"crossref","first-page":"00605","DOI":"10.1183\/23120541.00605-2022","article-title":"Nebulised interferon-beta1a (sng001) in hospitalised COVID-19: Sprinter phase iii study","volume":"9","author":"Monk","year":"2023","journal-title":"ERJ Open Res."},{"key":"ref_647","doi-asserted-by":"crossref","unstructured":"Ryoo, S., Koh, D.H., Yu, S.Y., Choi, M., Huh, K., Yeom, J.S., and Heo, J.Y. (2023). Clinical efficacy and safety of interferon (type i and type iii) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0296219"},{"key":"ref_648","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cmi.2022.04.016","article-title":"An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-beta-1a, and hydroxychloroquine in hospitalized patients with COVID-19: Final results","volume":"28","author":"Ader","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_649","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(22)00519-0","article-title":"Remdesivir and three other drugs for hospitalised patients with COVID-19: Final results of the who solidarity randomised trial and updated meta-analyses","volume":"399","author":"Consortium","year":"2022","journal-title":"Lancet"},{"key":"ref_650","doi-asserted-by":"crossref","first-page":"1198576","DOI":"10.3389\/fmed.2023.1198576","article-title":"Interferons in COVID-19: Missed opportunities to prove efficacy in clinical phase iii trials?","volume":"10","author":"Brzoska","year":"2023","journal-title":"Front. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/20\/11267\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:16:49Z","timestamp":1760113009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/20\/11267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,19]]},"references-count":650,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["ijms252011267"],"URL":"https:\/\/doi.org\/10.3390\/ijms252011267","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,19]]}}}